WO2021069698A1 - Healing and conductive composition comprising collagen - Google Patents

Healing and conductive composition comprising collagen Download PDF

Info

Publication number
WO2021069698A1
WO2021069698A1 PCT/EP2020/078473 EP2020078473W WO2021069698A1 WO 2021069698 A1 WO2021069698 A1 WO 2021069698A1 EP 2020078473 W EP2020078473 W EP 2020078473W WO 2021069698 A1 WO2021069698 A1 WO 2021069698A1
Authority
WO
WIPO (PCT)
Prior art keywords
collagen
composition according
skin
composition
gel
Prior art date
Application number
PCT/EP2020/078473
Other languages
French (fr)
Inventor
Emanuele MONDERNA
Original Assignee
Monderna Health & Wellness
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR1911195A external-priority patent/FR3101777B1/en
Priority claimed from FR1911192A external-priority patent/FR3101774A1/en
Application filed by Monderna Health & Wellness filed Critical Monderna Health & Wellness
Publication of WO2021069698A1 publication Critical patent/WO2021069698A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Definitions

  • the present invention relates to a particular composition based on collagens for use on the skin and / or mucous membranes, in particular for healing and / or as a conductive cream for the treatment of the skin and / or mucous membranes by diathermy and / or radio frequency.
  • Radiofrequency or diathermy is used in therapy and in cosmetics for various objectives such as, for example, to fight against the loss of skin tone, to fight against the redness of rosacea, to fight against cellulite, to promote the disappearance of residual marks on the skin. skin, etc.
  • a metal return plate is positioned and the operator holds a handle in his hand.
  • This handle can be ceramic (capacitive mode) or metal (resistive mode).
  • the metal handle can be in polar, spherical or flat resistive mode, and in this case it is not necessary to use a return plate because the two polarizations are in the handle.
  • the operator applies a neutral conductive cream without active principle.
  • a magnetic field is then created thanks to the two polarizations.
  • the body plays the role of conductor through its ions, which are charged water molecules. These molecules are mobilized and create endogenous heat. It results in an increase in the temperature of the tissues creating an activation of the dermis, which produces hyaluronic acid, collagen fibers and elastin fibers. This endogenous heat also induces vascularization, therefore an improvement in all internal exchanges.
  • the radiofrequency technique induces at the same time biochemical effects, mechanical effects and thermal effects.
  • radio frequencies oscillate between 300 KHz and 4 MHz, each frequency corresponding to a level of tissue resistance.
  • the frequency used is determined by the area to be treated and the desired goal.
  • conductive creams are generally neutral and contain synthetic or petrochemical ingredients.
  • the cream is conductive because it contains a majority of aqueous components.
  • the existing conductive creams are not satisfactory because they are neutral creams without cosmetic or therapeutic efficacy as such, and therefore have no added value. Their only effect is to allow the conduction and the sliding of the manipulates.
  • they are made up of petrochemical components, some with parabens and therefore unnatural and with endocrine disruptors.
  • these creams have the property of fluffing, which makes it necessary to apply a larger quantity to allow the manipulation of the handle.
  • the objective of the invention is to overcome these various problems of the prior art.
  • the efficiency of the radiofrequency can be increased by introducing into the conductive cream molecules of collagen, molecules of natural origin, thus also allowing the use of this same cream without the application of radiofrequency.
  • composition comprising a mixture of at least two kinds, two forms, of different collagens.
  • a composition comprising at least one particular collagen, namely at least one collagen obtained from sturgeon skins also makes it possible to meet the objective of the present invention.
  • Collagen is the most abundant structural protein in the body.
  • collagen within the meaning of the invention is meant either at least one particular form of collagen chosen from native collagen, gel collagen and hydrolyzed collagen, or a mixture of collagen comprising at least two collagen chosen from native collagen , a gel collagen and a hydrolyzed collagen, or a mixture of a native collagen, a gel collagen and a hydrolyzed collagen. It makes up about 70% of the connective tissue in the body and is necessary for building skin, muscles, bones and cartilage. Collagen ensures the cohesion, elasticity and regeneration of all these tissues. This protein is widely recognized as a functional ingredient thanks to its properties well known and identified for its health effects. 75% of the dermis is made up of collagen. From around 25-35 years of age, the body loses collagen at a rate of 1.5% per year.
  • Oral or topical collagen intake has been widely studied. Oral ingestion of collagen polypeptides has been shown to have positive effects on various body functions: bones, joints, skin, and tissues and ligaments.
  • Collagen is characterized by its triple helix shape. There are traditionally three kinds or three forms of collagen:
  • Native collagen has kept its native three-dimensional structure and the epitopes that allow it to interact with the immune system. Collagen in native form has not undergone any transformation and therefore corresponds to the entire protein. The native form is therefore difficult to assimilate by the organism. It is generally extracted gently at low temperature in an acidic medium because it is acid-soluble.
  • Collagen gel or collagen gel or medium molecular weight collagen gelatin is generally obtained by hot aqueous extraction or chemical processes (strong acids or alkali) from skin, cartilage and other tissues containing collagen. Widely used for the food and pharmaceutical industry (capsule), it contains 84 to 90% of proteins and 1 to 2% of mineral salts. Hot extraction causes depolymerization of the collagen triple helix, it is denatured. A protein is thus obtained in gelled form with a more flexible format called collagen gel or collagen gel. Collagen gelatin thus differs from certain products on the market and called gelatin which are mainly products based on agar-agar, pectin and do not include collagen gelatin. By this transformation, the protein is more assimilated by the body than the native collagen.
  • Collagen hydrolyzate or low molecular weight hydrolyzed collagen It is completely denatured collagen made up of all the amino acids that make up collagen. It is obtained by hydrolysis (enzymatic or acid) from raw materials containing collagen such as fish skins. It can also be obtained by hydrolysis of gel collagen. This hydrolysis splits the long collagen molecules into peptides and polypeptides (short chains of amino acids) which are bioavailable and therefore highly assimilable by the body.
  • Bovine collagen is extracted from the skin of dead cows, sterilized and liquefied. It can be injected into the lips to swell them or under the wrinkles to fade them. But the bovine collagen ends up being absorbed by the body; this is the reason why its effects only last about three months. Marine collagen is also used in wrinkle creams. Marine collagen is extracted from residues from the food industry, most often fish or shrimp waste.
  • Collagen of marine origin is increasingly used and sought after as an alternative to collagen of mammalian origin, for religious and health questions (eg BSE crisis).
  • Marine collagen is used in cosmetics and cosmetics in many products with different properties highlighted, such as a moisturizing, humectant and / or a film-forming effect and / or an anti-aging, cellular restructuring effect.
  • collagen of marine origin like collagen of bovine origin, is not entirely satisfactory and may contain heavy metals and residues which are not acceptable for use on the skin.
  • the species of sturgeon is Acipenser baerii and / or Acipenser gueldenstaedtii.
  • the collagens of sturgeon skins have a particular aminogram, since it contains about a third of Glycine and a high percentage of hydroxyproline and proline, and are of a higher purity than that of the collagens of marine fish.
  • the collagen obtained from the sturgeon skin makes it possible to avoid the presence of heavy metals in the collagens and therefore in the composition according to the invention.
  • the sturgeons used are preferably reared in closed tanks supplied with excellent quality spring water and can receive a so-called organic diet. This helps to eliminate the entry of contaminants that are usually found in the skin of fish.
  • a subject of the invention is a composition suitable for topical application to the skin or the mucous membranes, comprising at least water and at least one mixture of collagens, said mixture of collagen comprising at least: native collagen, native collagen molecules having molecular weights between 150 and 300,000 Daltons, and gel collagen, the gel collagen molecules having molecular weights between 100 and 150,000 Daltons.
  • the invention relates to a composition suitable for topical application to the skin or the mucous membranes comprising at least one collagen obtained from sturgeon skins.
  • the composition according to the invention comprises at least water and at least said mixture of collagens, said collagen being obtained from sturgeon skins.
  • such a composition in the form of a cream contains original components. natural, has good hold, has good conductivity, and can be used on the skin and / or mucous membranes for cosmetic or therapeutic applications, as a drug or medical device, alone or with the application of radiofrequencies
  • a subject of the invention is therefore also a composition for its use for the treatment of the skin and / or the mucous membranes, in particular as a medicament or a medical device, or alternatively as a cosmetic composition when it is applied to a skin and / or mucous membranes healthy (s) that is to say not diseased.
  • the invention relates to the composition for its use in topical application to the skin and / or the mucous membranes for a healing effect or for its use in topical application to the skin and / or the mucous membranes as a conductive composition for the treatment of skin and / or mucous membranes by diathermy or radiofrequency.
  • Figure la is a photograph of a skin explant showing the general morphology of an injured area, without OJ treatment.
  • Figure lb is a photograph of a skin explant showing the general morphology of an injured area, without treatment on D4.
  • Figure le is a photograph of a skin explant showing the general morphology of an injured area, with treatment with the composition according to the invention on D4.
  • Figure 2a is a photograph of a skin explant exhibiting the general morphology without OJ treatment.
  • Figure 2b is a photograph of a skin explant exhibiting the general morphology without treatment on D4.
  • Figure 2c is a photograph of a skin explant exhibiting the general morphology with treatment with the composition according to the invention on D4.
  • Figure 2d is a photograph of a skin explant showing the general morphology of an injured area, without treatment on D10.
  • Figure 2e is a photograph of a skin explant exhibiting the general morphology with treatment with the composition according to the invention on D10.
  • Figure 3a is a photograph of the abdomen of a 46 year old woman with postpartum stretch marks and scars following a tummy tuck.
  • Figure 3b is a control photograph of the abdomen one month after the end of the treatment (3 radiofrequency sessions with application of a composition according to the invention - 3 sessions spread over 45 days).
  • Figure 4 is a graphical representation of the different forms of collagen (native, gel or hydrolyzed collagen); LMW meaning “Low Molecular Weight” that is to say low molecular weight; MMH meaning “Medium Molecular Weight”, that is to say medium molecular weight; HMW meaning “High Molecular Weight” that is to say high molecular weight.
  • a subject of the invention is therefore a composition suitable for topical application to the skin or the mucous membranes, comprising: at least water, and at least one mixture of collagens, said mixture of collagens comprising at least:
  • gel collagen the gel collagen molecules having molecular weights between 100 and 150,000 Daltons.
  • the native collagen according to the invention has molecular weights of between 250,000 and 300,000 Daltons.
  • the gel collagen according to the invention has molecular weights of between 100,000 and 150,000 Daltons.
  • composition suitable for topical application to the skin or the mucous membranes comprising at least one collagen obtained from sturgeon skin, preferably from sturgeon ventral skin.
  • the sturgeon is I ’Acipenser baieri and / or I’ Acipenser gueldenstaedtii.
  • skin and “sturgeon”, the collagen (s) which may be derived from one or more skin (s) of one or more sturgeon (s). .
  • the collagen (s) obtained from sturgeon skin comprises (comprise): a glycine content of between 21 and 26%, a hydroxyproline content of between 8 and 18%, a proline content of between 9 and 14%.
  • the composition comprising at least one collagen obtained from sturgeon skin also comprises at least water.
  • the collagen (s) present in the composition according to the invention are type I collagens.
  • the composition according to the invention comprises at least one mixture of collagens, preferably obtained from sturgeon skin, said mixture of collagens comprising at least :
  • gel collagen the gel collagen molecules having molecular weights between 100 and 150,000 Daltons, and possibly water.
  • the composition according to the invention comprises a mixture of at least two kinds or two forms of collagens, preferably obtained from sturgeon skin, chosen from: native collagen, native collagen molecules having weights molecular weight between 150 and 300,000 Daltons, preferably between 250,000 and 300,000 Daltons of collagen in gel, collagen molecules in gel having molecular weights between 100 and 150,000 Daltons, preferably between 100,000 and 150,000 Daltons, a collagen hydrolyzate, molecules of the collagen hydrolyzate having molecular weights between 500 and 5000 Daltons, and possibly water.
  • native collagen native collagen molecules having weights molecular weight between 150 and 300,000 Daltons, preferably between 250,000 and 300,000 Daltons of collagen in gel
  • collagen molecules in gel having molecular weights between 100 and 150,000 Daltons, preferably between 100,000 and 150,000 Daltons
  • a collagen hydrolyzate molecules of the collagen hydrolyzate having molecular weights between 500 and 5000 Daltons, and possibly water.
  • the mixture of collagens preferably comprises between 10 and 40% of native collagen and between 60 and 90% of collagen in gel, the percentages being given by weight relative to the total weight of dry matter of the mixture of collagens.
  • the mixture of collagens comprises between 15 and 35% of native collagen and between 65 and 85% of collagen in gel, the percentages being given by weight relative to the total weight of dry matter of the mixture of collagens.
  • the collagen (s) obtained from sturgeon skin and / or the mixture of collagens comprising at least native collagen and gel collagen represents at least 0 , 1% by weight relative to the total weight of the composition, preferably between 0.1 and 10%, more preferably between 0.1 and 5%.
  • the native collagen it is preferred for the native collagen to be obtained by carrying out a process at a temperature below 35 ° C., so as to preserve the entire structure of the collagen without denaturing.
  • the mixture of collagens used in the compositions according to the invention can be of any origin. They can be, for example, collagens of mammalian origin, such as bovine collagens. extracts from the skin of dead cows.
  • Marine collagen can also be marine collagens.
  • Marine collagen can be extracted from food industry residues, such as fish or shrimp waste, or directly from fish skins.
  • marine collagen has a greater absorption capacity than collagen of mammalian origin.
  • marine collagen has a higher average proline and hydroxyproline content than animal collagen, which gives it less mechanical strength and lower viscosity.
  • the composition according to the invention comprises collagens obtained from fish skins.
  • the collagens are obtained from freshwater fish skins and even more preferably from sturgeon skins, and in particular from sturgeon ventral skins.
  • the collagen obtained from the skin of sturgeons makes it possible to avoid the presence of heavy metals in the collagens and therefore in the composition according to the invention.
  • the sturgeons used are preferably reared in closed tanks supplied with excellent quality spring water and can receive a so-called organic diet. This helps to eliminate the entry of contaminants that are usually found in the skin of fish.
  • the collagen (s) used in the compositions according to the invention exhibit an aminogram exhibiting at least the following characteristics: a glycine content of between 21 and 26%, a content in hydroxyproline between 8 and 18%, a proline content between 9 and 14%.
  • the composition according to the invention comprises at least water.
  • the composition according to the invention comprises between 50 and 95% water by weight relative to the total weight of the composition, very preferably between 65 and 80% water.
  • the water present in the composition according to the invention can be of any origin.
  • At least part of the water present in the composition according to the invention is source water.
  • Preferably at least 3% of the water present in the composition according to the invention is spring water, the percentage being given by weight relative to the total weight of water present in the composition.
  • At least part of the water present in the composition according to the invention is water of marine origin.
  • At least part of the water present in the composition is water from a marine source.
  • Preferably at least 3% of the water present in the composition according to the invention is marine spring water, the percentage being given by weight relative to the total weight of water present in the composition.
  • the composition according to the invention can comprise other constituents, these having to be dermatologically and / or cosmetically acceptable. They may in particular be excipients or active ingredients.
  • the composition according to the invention comprises: at least one vegetable oil, such as for example a sunflower or pomegranate or grape seed oil, and / or at least one active principle which heals and / or moisturizes and / or antibacterial and / or soothing and / or anti-irritant, such as for example squalane or aloe vera gel, and / or at least one plant extract, such as for example extract of punica granatum, or extract of flower of sophora japonica, or leaf extract rosemary, and / or at least one emulsifier, such as for example Sorbitan isostearate or polyacrylamide or polysorbate 20, and / or at least one emollient, such as for example octyldodecanol or propanediol or caprylic,
  • composition according to the invention can be provided in various forms suitable for topical application to the skin and / or the mucous membranes. It may in particular be a cream, a serum or a gel or a solution.
  • composition according to the invention can be obtained by any suitable manufacturing process.
  • the composition according to the invention can be obtained by a manufacturing process comprising at least the implementation of the following steps: obtaining at least one solution of collagen (s) from sturgeon skins, in the case of where there are several solutions of collagen (s), mixture of solutions of collagen (s), mixture of solution obtained with the possible other constituents of the composition.
  • the composition according to the invention can also be obtained by a manufacturing process comprising at least the implementation of the following steps: a. obtaining a native collagen solution, preferably from sturgeon skins, b. obtaining a gel collagen solution, preferably from sturgeon skins c. mixing the two solutions to obtain a solution of native collagen and gel collagen, d. mixing of the constituents of the composition at room temperature.
  • the native collagen solution can be obtained anywhere suitable medium.
  • step a. includes the implementation of the following steps:
  • washing of the raw material containing collagen, preferably fish skins, even more preferably sturgeon skins and in particular sturgeon ventral skins; the washing is preferably carried out in two sub-steps: o a basic washing with sodium hydroxide NaOH, to clean the skins o then with water to neutralize extraction with acid, filtration and centrifugation, precipitation of the collagen by NaCl and centrifugation, solubilization by addition of acid, dialysis to remove the salt (NaCl), tangential concentration.
  • a basic washing with sodium hydroxide NaOH to clean the skins o then with water to neutralize extraction with acid
  • filtration and centrifugation precipitation of the collagen by NaCl and centrifugation
  • solubilization by addition of acid
  • dialysis to remove the salt (NaCl), tangential concentration.
  • the process for obtaining native collagen is preferably carried out at a temperature below 35 ° C. It thus keeps its triple helix and its native collagen properties.
  • step b. includes the implementation of the following steps:
  • washing of the raw material containing collagen, preferably fish skins, even more preferably sturgeon skins and in particular sturgeon ventral skins; the washing is preferably carried out in two sub-steps: o a basic washing with sodium hydroxide NaOH, to clean the skins o then with water to neutralize extraction with acid filtration and centrifugation precipitation of collagen by NaCl and centrifugation, solubilization by addition of dialysis acid to remove the salt (NaCl) tangential concentration, cooking at 60 ° C., preferably with stirring, sieving, filtration through activated carbon.
  • a basic washing with sodium hydroxide NaOH to clean the skins o then with water to neutralize extraction with acid filtration and centrifugation precipitation of collagen by NaCl and centrifugation, solubilization by addition of dialysis acid to remove the salt (NaCl) tangential concentration, cooking at 60 ° C., preferably with stirring, sieving, filtration through activated carbon.
  • the two solutions are then mixed to form a collagen solution.
  • the collagen solution is then mixed with water and with the other optional constituents of the composition, preferably at room temperature in order to preserve the original qualities of the active agents and in particular of the ingredients of natural origin constituting the composition according to the invention.
  • the implementation of the process at ambient temperature is of economic and environmental interest.
  • composition according to the invention has an effectiveness on the skin and / or the mucous membranes, in particular a healing effectiveness.
  • a subject of the invention is therefore also the composition for its use in the treatment of the skin and / or the mucous membranes.
  • the composition can be used as a medicament, essentially as a dermatological medicament, or as a medical device or else as a cosmetic or dermocosmetic composition.
  • a subject of the invention is the composition for its use in topical application to the skin and / or the mucous membranes for a healing effect.
  • the invention also relates to the use of the composition on healthy skin or mucous membranes in topical application for a cosmetic effect, in particular for an anti-aging cosmetic effect, for preventing and / or combating skin aging.
  • the invention is also aimed at cosmetic use on healthy skin or mucous membranes in topical application for an anti-aging cosmetic effect, to prevent and / or fight against normal aging of the skin.
  • the composition according to the invention can also be used as a conductive cream for the treatment of the skin and / or the mucous membranes by diathermy and / or radiofrequency.
  • the therapeutic or cosmetic use of the composition according to the invention can therefore consist of this.
  • a subject of the invention is also the composition for its use. in topical application to the skin and / or the mucous membranes as a conductive composition for the treatment of the skin and / or the mucous membranes by diathermy and / or radiofrequency.
  • composition according to the invention can be used with or without application of radiofrequencies.
  • the composition is preferably applied in a circular manner to the area to be treated with the radiofrequency device so as to cover the entire surface and approximately 2 mm in thickness.
  • the practitioner then passes the manipulation over the area to be treated by following a protocol adapted to each pathological or cosmetic problem to be treated. If necessary, it is possible to add more cream while the protocol is being carried out.
  • the conductivity of the composition according to the invention is high.
  • the composition according to the invention is absorbed by the skin and acts as such through its intrinsic properties, thus supporting the recognized cosmetic or therapeutic regenerating properties of radiofrequency.
  • the radio frequency causes vasodilation in the area of application, increasing blood flow and raising the temperature locally causing better supply of nutrients and oxygen, and the elimination of catabolites.
  • the effects of radiofrequency temperature cause the denaturation of collagen in the dermis, promoting immediate and effective contraction of its fibers, activating fibroblasts and leading to neo-collagenization leading to the reorganization of collagen fibers and tissue remodeling.
  • the temperature on the surface of the skin reaches 40 to 42 ° C, and 50 to 60 ° C in depth.
  • the native collagen present in the composition according to the invention is denatured during the use of radiofrequency.
  • the triple helix chain is undone under the effect of heat (from 35 ° C); it penetrates the dermis more easily because its molecular weight will be lower and the vasodilation of the pores promotes its penetration into the dermis. This reinforces the effect of the collagen gel. Radio frequency can take collagen molecules deeper into the layers of the dermis.
  • composition according to the invention which is in the form of a cream, is obtained by mixing constituents at room temperature, which in the finished composition consists of (the contents being given in percentage by weight relative to the weight of the composition ): native collagen of sturgeon skins: 0.01 to 1 collagen gel of sturgeon skins: 0.01 to 1 glycerin: 0.2 to B squalane: 3 to 6 pomegranate oil: 1 to 2 flower extract of sophora japonica: 0.001 to 0.05 pomegranate extract: 0.001 to 0.05 essential oil of niaouli: 0.01 to 0.1 sunflower oil: 0.1 to 1 marine spring water: 2 to 5 - Water: 75 to 88 caprylic / capric triglyceride: 5 to 8 emulsifier: 1 to 3 preservatives: QS
  • compositions tested are described in Table 1 (collagen content values, percentage by weight relative to the total weight of the composition; the remainder of the composition is that of the example of composition according to the invention).
  • Histological treatments After 24 hours in buffered formalin, the samples were dehydrated and impregnated with paraffin using a Leica PEARL automatic dehydration machine. They have was en bloc using a Leica EG 1160 embedding station. 5 ⁇ m sections were made using a Minot type microtome, Leica RM 2125 and mounted on Superfrost histological glass slides. ® . The frozen samples were cut into sections 7 ⁇ m thick using a Leica CM 3050 cryostat. The sections were then mounted on Superfrost ® Plus glass slides. The microscopic observations were carried out by optical microscopy, using a Leica DMLB or Olympus BX43 type microscope. The shots were taken with an Olympus DP72 camera and Cell A D software.
  • the operating protocol for the test is as follows:
  • the explants of the control batches received no treatment except for the renewal of the culture medium, half (1mL / well) on D3.
  • composition P3 The results obtained with composition P3 are shown in Figures la (general morphology), lb (control at D4) and (invention at D4).
  • Figure la shows the general morphology of the injured area. There is no growth bud.
  • FIG. 1b represents the general morphology of the injured area of the untreated control on D4.
  • the growth bud has a length of 150 ⁇ m.
  • Figure 1c shows the general morphology of the injured area after 4 days of treatment with the composition according to the invention (PB).
  • the general morphology is good in the epidermis and in the dermis.
  • the stratum corneum has a thin and slightly laminated appearance, the relief of the dermo-epidermal junction (DEJ) is low and the density of the papillary dermis is clear.
  • DEJ dermo-epidermal junction
  • composition according to the invention after 4 days of treatment, exhibits greater healing activity than the control, mainly by promoting both the proliferation and the migration of the keratinocytes of the growth bud.
  • the PI product after 4 days of treatment, exhibits healing activity mainly by promoting the migration of keratinocytes and therefore the advancement of the growth bud. This activity is no longer observed after 10 days.
  • the product P2 after 4 days of treatment exhibits healing activity, mainly by promoting the proliferation of keratinocytes in the growth bud.
  • the product P3 after 4 days of treatment, exhibits healing activity, mainly by promoting both the proliferation and the migration of keratinocytes from the growth bud. After 10 days of treatment, it only promotes the proliferation of keratinocytes in the growth bud.
  • the product P4 after 4 days of treatment, does not exhibit any healing activity. But after 10 days of treatment, it promotes the proliferation of keratinocytes in the growth bud.
  • the product P5, after 4 or 10 days of treatment, does not exhibit any healing activity.
  • the operating protocol for the test is as follows:
  • the explants of the control batches received no treatment except for the renewal of the medium. of culture, for half (lmL / well) on JB, D5 and D7.
  • FIGS. 2a general morphology
  • 2b control on D4
  • 2c invention on D4
  • 2d control on D10
  • 2e invention on D10
  • FIG. 2a represents the morphology of the explant on normal skin.
  • the general morphology is good in the epidermis and in the dermis.
  • the stratum corneum has a thin and slightly laminated appearance, the relief of the dermo-epidermal junction (DEJ) is low and the density of the papillary dermis is clear.
  • DEJ dermo-epidermal junction
  • FIG. 2b represents the morphology of the explant without treatment on D4:
  • the general morphology is quite good in the epidermis and good in the dermis.
  • the stratum corneum presents a moderately thick and laminated appearance, the relief of the dermo-epidermal junction (DEJ) is moderate and the density of the papillary dermis is moderate.
  • DEJ dermo-epidermal junction
  • FIG. 2c represents the morphology of the explant after 4 days of application of the composition P3: the invention induces an increase in the density of the papillary dermis.
  • FIG. 2d represents the morphology of the explant without treatment after 10 days: the general morphology is very slightly altered in the epidermis and good in the dermis.
  • the stratum corneum presents a rather thick and moderately laminated appearance, the relief of the dermo-epidermal junction (DEJ) is moderate and the density of the papillary dermis is low.
  • DEJ dermo-epidermal junction
  • FIG. 2e represents the morphology of the explant after 10 days of application of the composition P3: the invention induces an increase in the density of the papillary dermis.
  • composition according to the invention is well tolerated by the skin and does not induce any deterioration in cell viability in the epidermis or in the dermis.
  • the composition according to the invention exhibits anti-aging activity by improving the density of the dermis which is clearly visible, and which continues on D10.
  • the PI product after 4 days of treatment, does not induce an increase in the density of the papillary dermis. An increase is seen after 10 days.
  • the product P2 after 4 days of treatment, does not induce an increase in the papillary dermis.
  • the PB product after 4 days of treatment and after 10 days of treatment, induces an increase in the density of the papillary dermis.
  • the product P4 after 4 days of treatment, does not induce an increase in the density of the papillary dermis. An increase is seen after 10 days.
  • Figure 3a is a photograph of the abdomen of a 46 year old woman with postpartum stretch marks and scarring following a tummy tuck. We see marked stretch marks with a "scale skin” appearance, and adherent vertical and horizontal scars.
  • FIG. 3b is a control photograph of the abdomen one month after the end of the treatment (3 radiofrequency sessions with application of the composition according to the invention spread over 45 days).
  • the skin is smoother, toned and elastic.
  • the horizontal and vertical scar is reduced. Stretch marks are extremely reduced.
  • the adhesion of the vertical scar has disappeared.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to a composition suitable for topical application on the skin or mucous membranes, characterised in that it comprises at least water and at least a mixture of collagens, the collagen mixture comprising at least: - native collagen, the native collagen molecules having molecular weights ranging from 150 to 300,000 daltons, and - collagen gel, the collagen gel molecules having molecular weights ranging from 100 to 150,000 daltons. The invention also relates to such a composition and the use thereof in the treatment of skin and/or mucous membranes and a method for producing such a composition.

Description

COMPOSITION CICATRISANTE ET CONDUCTRICE COMPRENANT DU HEALING AND CONDUCTIVE COMPOSITION INCLUDING
COLLAGENE COLLAGEN
La présente invention concerne une composition particulière à base de collagènes pour son utilisation sur la peau et/ou les muqueuses, en particulier pour la cicatrisation et/ou comme crème conductrice pour le traitement de la peau et/ou des muqueuses par diathermie et/ou radiofréquence. The present invention relates to a particular composition based on collagens for use on the skin and / or mucous membranes, in particular for healing and / or as a conductive cream for the treatment of the skin and / or mucous membranes by diathermy and / or radio frequency.
Etat de l'art State of the art
La radiofréquence ou la diathermie est utilisée en thérapie et en cosmétique pour différents objectifs tels que par exemple lutter contre la perte de tonicité de la peau, lutter contre les rougeurs de la couperose, lutter contre la cellulite, favoriser la disparition de marques résiduelles sur la peau, etc. Radiofrequency or diathermy is used in therapy and in cosmetics for various objectives such as, for example, to fight against the loss of skin tone, to fight against the redness of rosacea, to fight against cellulite, to promote the disappearance of residual marks on the skin. skin, etc.
En fonction de la zone à traiter et du but recherché, on positionne une plaque de retour métallique et l'opérateur tient un manipule dans sa main. Ce manipule peut être en céramique (mode capacitif) ou en métal (mode résistif). Selon une variante, le manipule en métal peut être en mode résistif polaire, sphérique ou plat, et dans ce cas il n'est pas nécessaire d'utiliser une plaque de retour car les deux polarisations sont dans le manipule. Depending on the area to be treated and the desired goal, a metal return plate is positioned and the operator holds a handle in his hand. This handle can be ceramic (capacitive mode) or metal (resistive mode). According to a variant, the metal handle can be in polar, spherical or flat resistive mode, and in this case it is not necessary to use a return plate because the two polarizations are in the handle.
Entre le manipule et la peau du sujet, l'opérateur applique une crème conductrice neutre sans principe actif. Il se crée alors un champ magnétique grâce aux deux polarisations. Le corps joue le rôle de conducteur de par ses ions, qui sont les molécules d'eau chargées. Ces molécules sont mobilisées et créent une chaleur endogène. Elle se traduit par une augmentation de la température des tissus créant une activation du derme, productrice d'acide hyaluronique, de fibres de collagène et de fibres d'élastine. Cette chaleur endogène induit également une vascularisation, donc une amélioration de tous les échanges internes. Ainsi la technique de radiofréquence induit à la fois des effets biochimiques, des effets mécaniques et des effets thermiques. Between the manipulator and the subject's skin, the operator applies a neutral conductive cream without active principle. A magnetic field is then created thanks to the two polarizations. The body plays the role of conductor through its ions, which are charged water molecules. These molecules are mobilized and create endogenous heat. It results in an increase in the temperature of the tissues creating an activation of the dermis, which produces hyaluronic acid, collagen fibers and elastin fibers. This endogenous heat also induces vascularization, therefore an improvement in all internal exchanges. Thus the radiofrequency technique induces at the same time biochemical effects, mechanical effects and thermal effects.
Actuellement, les radiofréquences oscillent entre 300 KHz et 4 MHz, chaque fréquence correspondant à un niveau de résistance tissulaire. La fréquence utilisée est déterminée par la zone à traiter et le but recherché. Currently, radio frequencies oscillate between 300 KHz and 4 MHz, each frequency corresponding to a level of tissue resistance. The frequency used is determined by the area to be treated and the desired goal.
Pour la mise en oeuvre de cette technique et le bon fonctionnement des dispositifs, il est obligatoire d'utiliser une crème permettant la conduction des ondes entre le manipule et le tissu. For the implementation of this technique and the proper functioning of the devices, it is mandatory to use a cream allowing the conduction of the waves between the manipulator and the tissue.
Les crèmes conductrices actuelles sont généralement neutres et contiennent des ingrédients de synthèse ou issus de la pétrochimie. La crème est conductrice car elle contient une majorité de composants aqueux. Les crèmes conductrices existantes ne sont pas satisfaisantes car ce sont des crèmes neutres sans efficacité cosmétique ou thérapeutique en tant que telles, et sont donc sans valeur ajoutée. Leur seul effet est de permettre la conduction et le glissement du manipule. En outre, elles sont constituées de composants pétrochimiques, certaines avec des parabènes donc non naturels et avec des perturbateurs endocriniens. De plus, ces crèmes ont la propriété de pelucher ce qui oblige à en appliquer une quantité plus importante pour permettre le glissement du manipule. Current conductive creams are generally neutral and contain synthetic or petrochemical ingredients. The cream is conductive because it contains a majority of aqueous components. The existing conductive creams are not satisfactory because they are neutral creams without cosmetic or therapeutic efficacy as such, and therefore have no added value. Their only effect is to allow the conduction and the sliding of the manipulates. In addition, they are made up of petrochemical components, some with parabens and therefore unnatural and with endocrine disruptors. In addition, these creams have the property of fluffing, which makes it necessary to apply a larger quantity to allow the manipulation of the handle.
L'objectif de l'invention est de pallier ces différentes problématiques de l'art antérieur. The objective of the invention is to overcome these various problems of the prior art.
Résumé de l'invention Summary of the invention
Selon l'invention, l'efficacité de la radiofréquence peut être augmentée en introduisant dans la crème conductrice des molécules de collagène, molécules d'origine naturelle, permettant ainsi également l'utilisation de cette même crème sans application de radiofréquence. According to the invention, the efficiency of the radiofrequency can be increased by introducing into the conductive cream molecules of collagen, molecules of natural origin, thus also allowing the use of this same cream without the application of radiofrequency.
C'est pourquoi, pour répondre à l'objectif de l'invention, l'inventeur a mis au point une composition comprenant un mélange d'au moins deux sortes, deux formes, de collagènes différents. This is why, to meet the objective of the invention, the inventor has developed a composition comprising a mixture of at least two kinds, two forms, of different collagens.
Selon une variante, une composition comprenant au moins un collagène particulier à savoir au moins un collagène obtenu à partir de peaux d'esturgeon permet également de répondre à l'objectif de la présente invention. According to one variant, a composition comprising at least one particular collagen, namely at least one collagen obtained from sturgeon skins also makes it possible to meet the objective of the present invention.
Le collagène est la protéine structurelle la plus abondante dans le corps. Par « collagène » au sens de l'invention, on entend soit au moins une forme particulière de collagène choisi parmi un collagène natif, un collagène gel et un collagène hydrolysé, soit un mélange de collagène comprenant au moins deux collagène choisi parmi un collagène natif, un collagène gel et un collagène hydrolysé, soit un mélange d'un collagène natif, d'un collagène gel et d'un collagène hydrolysé. Il représente environ 70% du tissu conjonctif du corps et est nécessaire à la constitution de la peau, des muscles, des os et du cartilage. Le collagène assure la cohésion, l'élasticité et la régénération de tous ces tissus. Cette protéine est largement reconnue en tant qu'ingrédient fonctionnel grâce à ses propriétés bien connues et identifiées pour ses effets santé. 75% du derme est constitué de collagène. A partir d'environ 25-35 ans, le corps perd du collagène à un taux de 1.5% par an. Collagen is the most abundant structural protein in the body. By “collagen” within the meaning of the invention is meant either at least one particular form of collagen chosen from native collagen, gel collagen and hydrolyzed collagen, or a mixture of collagen comprising at least two collagen chosen from native collagen , a gel collagen and a hydrolyzed collagen, or a mixture of a native collagen, a gel collagen and a hydrolyzed collagen. It makes up about 70% of the connective tissue in the body and is necessary for building skin, muscles, bones and cartilage. Collagen ensures the cohesion, elasticity and regeneration of all these tissues. This protein is widely recognized as a functional ingredient thanks to its properties well known and identified for its health effects. 75% of the dermis is made up of collagen. From around 25-35 years of age, the body loses collagen at a rate of 1.5% per year.
L'apport en collagène sous forme orale ou topique a été largement étudié. Il a été démontré que l'ingestion orale de polypeptides de collagène a des effets positifs sur diverses fonctions du corps : les os, les articulations, la peau et les tissus et ligaments. Oral or topical collagen intake has been widely studied. Oral ingestion of collagen polypeptides has been shown to have positive effects on various body functions: bones, joints, skin, and tissues and ligaments.
Les premières utilisations du collagène dans une crème de beauté sont assez anciennes, et on peut trouver des traces de son utilisation dès 1936. L'intensification de son utilisation par l'industrie cosmétique se situe à partir des années 70. Ceci provient des études menées sur le vieillissement cutané. Son rôle dans la peau était connu depuis longtemps, mais de nombreuses équipes ont alors montré les modifications de la matrice extracellulaire lors du vieillissement cutané, et, en particulier, le rôle et l'implication du collagène dans le vieillissement. The first uses of collagen in a beauty cream are quite old, and traces of its use can be found as early as 1936. The intensification of its use by the cosmetics industry is from the 1970s. This comes from studies carried out. on skin aging. Its role in the skin was known for a long time, but many teams then showed the modifications of the extracellular matrix during skin aging, and, in particular, the role and involvement of collagen in aging.
Le collagène est caractérisé par sa forme en triple hélice. On trouve traditionnellement trois sortes ou trois formes de collagène : Collagen is characterized by its triple helix shape. There are traditionally three kinds or three forms of collagen:
Le collagène non dénaturé ou natif à haut poids moléculaire. Le collagène natif a gardé sa structure tridimensionnelle native et les épitopes qui lui permettent les interactions avec le système immunitaire. Le collagène sous forme native n'a pas subi de transformation et correspond donc à la protéine entière. La forme native est donc peu assimilable par l'organisme. Il est généralement extrait en voie douce à basse température en milieu acide car il est acido-soluble. Undenatured or native high molecular weight collagen. Native collagen has kept its native three-dimensional structure and the epitopes that allow it to interact with the immune system. Collagen in native form has not undergone any transformation and therefore corresponds to the entire protein. The native form is therefore difficult to assimilate by the organism. It is generally extracted gently at low temperature in an acidic medium because it is acid-soluble.
Le collagène en gel ou collagène gel ou gélatine de collagène à poids moléculaire moyen. La gélatine de collagène est obtenue généralement par extraction aqueuse à chaud ou procédés chimiques (acides forts ou alcalin) à partir de peaux, de cartilage et autres tissus contenant du collagène. Très utilisée pour l'industrie alimentaire et pharmaceutique (gélule), elle contient 84 à 90 % de protéines et 1 à 2% de sels minéraux. L'extraction à chaud provoque la dépolymérisation de la triple hélice de collagène, il est dénaturé. On obtient ainsi une protéine sous forme gélifiée avec un format plus souple dénommé collagène gel ou collagène en gel. La gélatine de collagène diffère ainsi de certains produits sur le marché et dénommé gélatine qui sont majoritairement des produits à base d'agar-agar, pectine et ne comprennent pas de gélatine de collagène. Par cette transformation, la protéine est plus assimilable par l'organisme que le collagène natif. Collagen gel or collagen gel or medium molecular weight collagen gelatin. Collagen gelatin is generally obtained by hot aqueous extraction or chemical processes (strong acids or alkali) from skin, cartilage and other tissues containing collagen. Widely used for the food and pharmaceutical industry (capsule), it contains 84 to 90% of proteins and 1 to 2% of mineral salts. Hot extraction causes depolymerization of the collagen triple helix, it is denatured. A protein is thus obtained in gelled form with a more flexible format called collagen gel or collagen gel. Collagen gelatin thus differs from certain products on the market and called gelatin which are mainly products based on agar-agar, pectin and do not include collagen gelatin. By this transformation, the protein is more assimilated by the body than the native collagen.
L'hydrolysat de collagène ou collagène hydrolysé à bas poids moléculaire. Il s'agit de collagène complètement dénaturé constitué de l'ensemble des acides aminés constitutifs du collagène. Il est obtenu par hydrolyse (enzymatique ou acide) à partir de matières premières contenant du collagène comme des peaux de poissons. Il peut être également obtenu par hydrolyse du collagène gel. Cette hydrolyse scinde les longues molécules de collagène en peptides et polypeptides (chaînes courtes d'acides aminés) biodisponibles et donc fortement assimilables par l'organisme. Collagen hydrolyzate or low molecular weight hydrolyzed collagen. It is completely denatured collagen made up of all the amino acids that make up collagen. It is obtained by hydrolysis (enzymatic or acid) from raw materials containing collagen such as fish skins. It can also be obtained by hydrolysis of gel collagen. This hydrolysis splits the long collagen molecules into peptides and polypeptides (short chains of amino acids) which are bioavailable and therefore highly assimilable by the body.
Il existe également plusieurs sources de collagène. Le collagène bovin est extrait de la peau de vaches mortes, stérilisé et liquéfié. On peut l'injecter dans les lèvres pour les gonfler ou sous les rides pour les estomper. Mais le collagène bovin finit par être absorbé par le corps ; c'est la raison pour laquelle ses effets ne durent que trois mois environ. Le collagène marin est également utilisé dans les crèmes antirides. Le collagène marin est extrait de résidus de l'industrie agroalimentaire, le plus souvent des déchets de poissons ou de crevettes. There are also several sources of collagen. Bovine collagen is extracted from the skin of dead cows, sterilized and liquefied. It can be injected into the lips to swell them or under the wrinkles to fade them. But the bovine collagen ends up being absorbed by the body; this is the reason why its effects only last about three months. Marine collagen is also used in wrinkle creams. Marine collagen is extracted from residues from the food industry, most often fish or shrimp waste.
Le collagène d'origine marine est de plus en plus utilisé et recherché en alternative au collagène d'origine mammalienne, pour des questions religieuses et sanitaires (crise de l'ESB par exemple).Collagen of marine origin is increasingly used and sought after as an alternative to collagen of mammalian origin, for religious and health questions (eg BSE crisis).
Le collagène marin est utilisé en cosmétique et cosmétique dans de nombreux produits avec différentes propriétés mises en avant telles qu'un effet hydratant, humectant et/ou un effet filmogène et/ou un effet anti-âge, restructurant cellulaire. Marine collagen is used in cosmetics and cosmetics in many products with different properties highlighted, such as a moisturizing, humectant and / or a film-forming effect and / or an anti-aging, cellular restructuring effect.
Toutefois, le collagène d'origine marine, comme le collagène d'origine bovine, n'est pas entièrement satisfaisant et peut comporter des métaux lourds et des résidus qui ne sont pas acceptables pour une utilisation sur la peau. However, collagen of marine origin, like collagen of bovine origin, is not entirely satisfactory and may contain heavy metals and residues which are not acceptable for use on the skin.
Selon l'invention, pour répondre aux objectifs recherchés, il est nécessaire d'utiliser au moins du collagène en gel et/ou du collagène natif et/ou du collagène de peaux de poissons d'eau douce et en particulier de peaux d'esturgeons. Préférentiellement, l'espèce de l'esturgeon est Acipenser baerii et/ou Acipenser gueldenstaedtii. According to the invention, to meet the desired objectives, it is necessary to use at least gel collagen and / or native collagen and / or collagen from freshwater fish skins and in particular sturgeon skins. . Preferably, the species of sturgeon is Acipenser baerii and / or Acipenser gueldenstaedtii.
Les collagènes de peaux d'esturgeons présentent un aminogramme particulier, puisqu'il compte environ un tiers de Glycine et un pourcentage élevé d'hydroxyproline et de proline, et sont d'une pureté plus importante que celle des collagènes de poissons marins. The collagens of sturgeon skins have a particular aminogram, since it contains about a third of Glycine and a high percentage of hydroxyproline and proline, and are of a higher purity than that of the collagens of marine fish.
Avantageusement, le collagène issu de la peau d'esturgeon permet d'éviter la présence de métaux lourds dans les collagènes et donc dans la composition selon l'invention. Les esturgeons utilisés sont préférentiellement élevés dans des bassins clos alimentés en eau de source d'excellente qualité et peuvent recevoir une alimentation dite biologique. Cela permet d'éliminer l'entrée de contaminants qui se retrouvent généralement dans la peau des poissons. Advantageously, the collagen obtained from the sturgeon skin makes it possible to avoid the presence of heavy metals in the collagens and therefore in the composition according to the invention. The sturgeons used are preferably reared in closed tanks supplied with excellent quality spring water and can receive a so-called organic diet. This helps to eliminate the entry of contaminants that are usually found in the skin of fish.
Ainsi, l'invention a pour objet une composition adaptée à une application topique sur la peau ou les muqueuses, comprenant au moins de l'eau et au moins un mélange de collagènes, ledit mélange de collagène comprenant au moins : du collagène natif, les molécules de collagène natif présentant des poids moléculaires compris entre 150 et 300000 Daltons, et du collagène en gel, les molécules de collagène en gel présentant des poids moléculaires compris entre 100 et 150000 Daltons. Thus, a subject of the invention is a composition suitable for topical application to the skin or the mucous membranes, comprising at least water and at least one mixture of collagens, said mixture of collagen comprising at least: native collagen, native collagen molecules having molecular weights between 150 and 300,000 Daltons, and gel collagen, the gel collagen molecules having molecular weights between 100 and 150,000 Daltons.
Selon une variante, l'invention concerne une composition adaptée à une application topique sur la peau ou les muqueuses comprenant au moins un collagène obtenu à partir de peaux d'esturgeon. Préférentiellement, la composition selon l'invention comprend au moins de l'eau et au moins ledit mélange de collagènes, ledit collagène étant obtenu à partir de peaux d'esturgeon. Avantageusement, une telle composition sous forme de crème contient des composants d'origine naturelle, a une bonne tenue, présente une bonne conductivité, et peut être utilisée sur la peau et/ou les muqueuses pour des applications cosmétiques ou thérapeutiques, comme médicament ou dispositif médical, seule ou avec l'application de radiofréquences According to one variant, the invention relates to a composition suitable for topical application to the skin or the mucous membranes comprising at least one collagen obtained from sturgeon skins. Preferably, the composition according to the invention comprises at least water and at least said mixture of collagens, said collagen being obtained from sturgeon skins. Advantageously, such a composition in the form of a cream contains original components. natural, has good hold, has good conductivity, and can be used on the skin and / or mucous membranes for cosmetic or therapeutic applications, as a drug or medical device, alone or with the application of radiofrequencies
L'invention a donc également pour objet une composition pour son utilisation pour le traitement de la peau et/ou des muqueuses, en particulier comme médicament ou dispositif médical, ou encore comme composition cosmétique lorsqu'elle est appliquée sur une peau et/ou des muqueuses saine(s) c'est-à-dire non malade(s). Notamment l'invention a pour objet la composition pour son utilisation en application topique sur la peau et/ou les muqueuses pour un effet cicatrisant ou pour son utilisation en application topique sur la peau et/ou les muqueuses comme composition conductrice pour le traitement de la peau et/ou des muqueuses par diathermie ou radiofréquence. Brève description des Figures A subject of the invention is therefore also a composition for its use for the treatment of the skin and / or the mucous membranes, in particular as a medicament or a medical device, or alternatively as a cosmetic composition when it is applied to a skin and / or mucous membranes healthy (s) that is to say not diseased. In particular, the invention relates to the composition for its use in topical application to the skin and / or the mucous membranes for a healing effect or for its use in topical application to the skin and / or the mucous membranes as a conductive composition for the treatment of skin and / or mucous membranes by diathermy or radiofrequency. Brief Description of Figures
[Figure la] : la figure la est une photographie d'un expiant de peau présentant la morphologie générale d'une zone lésée, sans traitement à JO. [Figure la]: Figure la is a photograph of a skin explant showing the general morphology of an injured area, without OJ treatment.
[Figure lb] : la figure lb est une photographie d'un expiant de peau présentant la morphologie générale d'une zone lésée, sans traitement à J4. [Figure lb]: Figure lb is a photograph of a skin explant showing the general morphology of an injured area, without treatment on D4.
[Figure le] : la figure le est une photographie d'un expiant de peau présentant la morphologie générale d'une zone lésée, avec traitement avec la composition selon l'invention à J4. [Figure le]: Figure le is a photograph of a skin explant showing the general morphology of an injured area, with treatment with the composition according to the invention on D4.
[Figure 2a] : la figure 2a est une photographie d'un expiant de peau présentant la morphologie générale sans traitement à JO. [Figure 2a]: Figure 2a is a photograph of a skin explant exhibiting the general morphology without OJ treatment.
[Figure 2b] : la figure 2b est une photographie d'un expiant de peau présentant la morphologie générale sans traitement à J4. [Figure 2b]: Figure 2b is a photograph of a skin explant exhibiting the general morphology without treatment on D4.
[Figure 2c] : la figure 2c est une photographie d'un expiant de peau présentant la morphologie générale avec traitement avec la composition selon l'invention à J4. [Figure 2c]: Figure 2c is a photograph of a skin explant exhibiting the general morphology with treatment with the composition according to the invention on D4.
[Figure 2d] : la figure 2d est une photographie d'un expiant de peau présentant la morphologie générale d'une zone lésée, sans traitement à J10. [Figure 2d]: Figure 2d is a photograph of a skin explant showing the general morphology of an injured area, without treatment on D10.
[Figure 2e] : la figure 2e est une photographie d'un expiant de peau présentant la morphologie générale avec traitement avec la composition selon l'invention à J10. [Figure 2e]: Figure 2e is a photograph of a skin explant exhibiting the general morphology with treatment with the composition according to the invention on D10.
[Figure 3a] : la figure 3a est une photographie de l'abdomen d'une femme de 46 ans présentant des vergetures post-partum et des cicatrices suite à une abdominoplastie. [Figure 3a]: Figure 3a is a photograph of the abdomen of a 46 year old woman with postpartum stretch marks and scars following a tummy tuck.
[Figure 3b] : la figure 3b est une photographie de contrôle de l'abdomen un mois après la fin du traitement (3 séances de radiofréquence avec application d'une composition selon l'invention - 3 séances réparties sur 45 jours). [Figure 3b]: Figure 3b is a control photograph of the abdomen one month after the end of the treatment (3 radiofrequency sessions with application of a composition according to the invention - 3 sessions spread over 45 days).
[Figure 4] : la figure 4 est une représentation graphique des différentes forme de collagène (natif, collagène gel ou hydrolysé) ; LMW signifiant « Low Molecular Weight » c'est-à-dire bas poids moléculaire ; MMH signifiant « Medium Molecular Weight » c'est-à-dire moyen poids moléculaire ; HMW signifiant « Hight Molecular Weight » c'est-à-dire haut poids moléculaire. [Figure 4]: Figure 4 is a graphical representation of the different forms of collagen (native, gel or hydrolyzed collagen); LMW meaning “Low Molecular Weight” that is to say low molecular weight; MMH meaning “Medium Molecular Weight”, that is to say medium molecular weight; HMW meaning "High Molecular Weight" that is to say high molecular weight.
Description détaillée Composition selon l'invention Detailed description Composition according to the invention
L'invention a donc pour objet une composition adaptée à une application topique sur la peau ou les muqueuses, comprenant : au moins de l'eau, et au moins un mélange de collagènes, ledit mélange de collagènes comprenant au moins : A subject of the invention is therefore a composition suitable for topical application to the skin or the mucous membranes, comprising: at least water, and at least one mixture of collagens, said mixture of collagens comprising at least:
• du collagène natif, les molécules de collagène natif présentant des poids moléculaires compris entre 150 et 300000 Daltons, et • native collagen, native collagen molecules with molecular weights between 150 and 300,000 Daltons, and
• du collagène en gel, les molécules de collagène en gel présentant des poids moléculaires compris entre 100 et 150000 Daltons. • gel collagen, the gel collagen molecules having molecular weights between 100 and 150,000 Daltons.
Préférentiellement, le collagène natif selon l'invention présente des poids moléculaires compris entre 250000 et 300000 Daltons. Préférentiellement, le collagène en gel selon l'invention présente des poids moléculaires compris entre 100000 et 150000 Daltons. Preferably, the native collagen according to the invention has molecular weights of between 250,000 and 300,000 Daltons. Preferably, the gel collagen according to the invention has molecular weights of between 100,000 and 150,000 Daltons.
L'invention a également pour autre objet une composition adaptée à une application topique sur la peau ou les muqueuses, comprenant au moins un collagène obtenu à partir de peau d'esturgeon, préférentiellement à partir de peau ventrale d'esturgeon. En particulier, l'esturgeon est I ’Acipenser baerii et/ou I ’Acipenser gueldenstaedtii. Dans la présente demande on utilise indifféremment le singulier et le pluriel pour les termes « peau » et « esturgeon » le ou les collagène(s) pouvant être issus d'une ou plusieurs peau(x) d'un ou plusieurs esturgeon(s). Another subject of the invention is a composition suitable for topical application to the skin or the mucous membranes, comprising at least one collagen obtained from sturgeon skin, preferably from sturgeon ventral skin. In particular, the sturgeon is I ’Acipenser baerii and / or I’ Acipenser gueldenstaedtii. In the present application, the singular and the plural are used interchangeably for the terms “skin” and “sturgeon”, the collagen (s) which may be derived from one or more skin (s) of one or more sturgeon (s). .
Préférentiellement, le ou les collagènes obtenu(s) à partir de peau d'esturgeon comprend (comprennent) : une teneur en Glycine comprise entre 21 et 26%, une teneur en hydroxyproline comprise entre 8 et 18%, une teneur en proline comprise entre 9 et 14%. Preferably, the collagen (s) obtained from sturgeon skin comprises (comprise): a glycine content of between 21 and 26%, a hydroxyproline content of between 8 and 18%, a proline content of between 9 and 14%.
Préférentiellement, la composition comprenant au moins un collagène obtenu à partir de peau d'esturgeon, comprend également au moins de l'eau. Preferably, the composition comprising at least one collagen obtained from sturgeon skin, also comprises at least water.
Préférentiellement, le(s) collagène(s) présent(s) dans la composition selon l'invention sont des collagènes de type I. Preferably, the collagen (s) present in the composition according to the invention are type I collagens.
Préférentiellement, la composition selon l'invention comprend au moins un mélange de collagènes, préférentiellement obtenus à partir de peau d'esturgeon, ledit mélange de collagènes comprenant au moins : Preferably, the composition according to the invention comprises at least one mixture of collagens, preferably obtained from sturgeon skin, said mixture of collagens comprising at least :
• du collagène natif, les molécules de collagène natif présentant des poids moléculaires compris entre 150 et 300000 Daltons, et • native collagen, native collagen molecules with molecular weights between 150 and 300,000 Daltons, and
• du collagène en gel, les molécules de collagène en gel présentant des poids moléculaires compris entre 100 et 150000 Daltons, et éventuellement de l'eau. • gel collagen, the gel collagen molecules having molecular weights between 100 and 150,000 Daltons, and possibly water.
Selon une variante, la composition selon l'invention comprend un mélange d'au moins deux sortes ou deux formes de collagènes, préférentiellement obtenus à partir de peau d'esturgeon, choisis parmi : du collagène natif, les molécules de collagène natif présentant des poids moléculaires compris entre 150 et 300000 Daltons, préférentiellement compris entre 250000 et 300000 Daltons du collagène en gel, les molécules de collagène en gel présentant des poids moléculaires compris entre 100 et 150000 Daltons, préférentiellement compris entre 100000 et 150000 Daltons un hydrolysat de collagène, les molécules de l'hydrolysat de collagène présentant des poids moléculaires compris entre 500 et 5000 Daltons, et éventuellement de l'eau. According to one variant, the composition according to the invention comprises a mixture of at least two kinds or two forms of collagens, preferably obtained from sturgeon skin, chosen from: native collagen, native collagen molecules having weights molecular weight between 150 and 300,000 Daltons, preferably between 250,000 and 300,000 Daltons of collagen in gel, collagen molecules in gel having molecular weights between 100 and 150,000 Daltons, preferably between 100,000 and 150,000 Daltons, a collagen hydrolyzate, molecules of the collagen hydrolyzate having molecular weights between 500 and 5000 Daltons, and possibly water.
Le mélange de collagènes comprend préférentiellement entre 10 et 40% de collagène natif et entre 60 et 90% de collagène en gel, les pourcentages étant donnés en poids par rapport au poids total de matières sèches du mélange de collagènes. Selon un mode de réalisation le mélange de collagènes comprend entre 15 et 35 % de collagène natif et entre 65 et 85% de collagène en gel, les pourcentages étant donnés en poids par rapport au poids total de matières sèches du mélange de collagènes. The mixture of collagens preferably comprises between 10 and 40% of native collagen and between 60 and 90% of collagen in gel, the percentages being given by weight relative to the total weight of dry matter of the mixture of collagens. According to one embodiment, the mixture of collagens comprises between 15 and 35% of native collagen and between 65 and 85% of collagen in gel, the percentages being given by weight relative to the total weight of dry matter of the mixture of collagens.
Dans la composition selon l'invention, le(s) collagène(s) obtenu(s) à partir de peau d'esturgeon et/ou le mélange de collagènes comprenant au moins du collagène natif et du collagène en gel, représente au moins 0,1% en poids par rapport au poids total de la composition, préférentiellement entre 0,1 et 10%, plus préférentiellement entre 0,1 et 5%. In the composition according to the invention, the collagen (s) obtained from sturgeon skin and / or the mixture of collagens comprising at least native collagen and gel collagen represents at least 0 , 1% by weight relative to the total weight of the composition, preferably between 0.1 and 10%, more preferably between 0.1 and 5%.
Selon l'invention, il est préféré que le collagène natif soit obtenu par la mise en oeuvre d'un procédé à une température inférieure à 35°C, de façon à préserver toute la structure du collagène sans dénaturation. According to the invention, it is preferred for the native collagen to be obtained by carrying out a process at a temperature below 35 ° C., so as to preserve the entire structure of the collagen without denaturing.
Le mélange des collagènes utilisés dans les compositions selon l'invention peut être de toute origine. Il peut s'agir par exemple de collagènes d'origine mammalienne, tels que des collagènes bovins extraits de la peau de vaches mortes. The mixture of collagens used in the compositions according to the invention can be of any origin. They can be, for example, collagens of mammalian origin, such as bovine collagens. extracts from the skin of dead cows.
Il peut s'agir également de collagènes marins. Le collagène marin peut être extrait de résidus de l'industrie agroalimentaire, tels que de déchets de poissons ou de crevettes ou bien directement de peaux de poissons. Avantageusement, le collagène marin a une plus grande capacité d'absorption que le collagène d'origine mammalienne. Par ailleurs, le collagène marin a une teneur en proline et hydroxyproline en moyenne plus élevée que le collagène animal, ce qui lui confère une moins grande résistance mécanique et une plus faible viscosité. It can also be marine collagens. Marine collagen can be extracted from food industry residues, such as fish or shrimp waste, or directly from fish skins. Advantageously, marine collagen has a greater absorption capacity than collagen of mammalian origin. Furthermore, marine collagen has a higher average proline and hydroxyproline content than animal collagen, which gives it less mechanical strength and lower viscosity.
Il peut s'agir aussi de collagènes obtenus à partir de peaux de poissons d'eau douce. It can also be collagens obtained from the skins of freshwater fish.
Selon un mode de réalisation préféré, la composition selon l'invention comprend des collagènes obtenus à partir de peaux de poissons. Préférentiellement, les collagènes sont obtenus à partir de peaux de poissons d'eau douce et encore plus préférentiellement de peaux d'esturgeons, et en particulier de peaux ventrales d'esturgeons. According to a preferred embodiment, the composition according to the invention comprises collagens obtained from fish skins. Preferably, the collagens are obtained from freshwater fish skins and even more preferably from sturgeon skins, and in particular from sturgeon ventral skins.
Avantageusement, le collagène issu de la peau d'esturgeons permet d'éviter la présence de métaux lourds dans les collagènes et donc dans la composition selon l'invention. Les esturgeons utilisés sont préférentiellement élevés dans des bassins clos alimentés en eau de source d'excellente qualité et peuvent recevoir une alimentation dite biologique. Cela permet d'éliminer l'entrée de contaminants qui se retrouvent généralement dans la peau des poissons. Advantageously, the collagen obtained from the skin of sturgeons makes it possible to avoid the presence of heavy metals in the collagens and therefore in the composition according to the invention. The sturgeons used are preferably reared in closed tanks supplied with excellent quality spring water and can receive a so-called organic diet. This helps to eliminate the entry of contaminants that are usually found in the skin of fish.
Selon un mode de réalisation particulièrement adapté, le(s) collagène(s) utilisé(s) dans les compositions selon l'invention présentent un aminogramme présentant au moins les caractéristiques suivantes : une teneur en Glycine comprise entre 21 et 26%, une teneur en hydroxyproline comprise entre 8 et 18%, une teneur en proline comprise entre 9 et 14%. According to a particularly suitable embodiment, the collagen (s) used in the compositions according to the invention exhibit an aminogram exhibiting at least the following characteristics: a glycine content of between 21 and 26%, a content in hydroxyproline between 8 and 18%, a proline content between 9 and 14%.
En plus du mélange de collagènes et/ou du ou des collagène(s) de peau d'esturgeon, la composition selon l'invention comprend au moins de l'eau. Préférentiellement, la composition selon l'invention comprend entre 50 et 95% d'eau en poids par rapport au poids total de la composition, très préférentiellement entre 65 et 80% d'eau. In addition to the mixture of collagens and / or of the sturgeon skin collagen (s), the composition according to the invention comprises at least water. Preferably, the composition according to the invention comprises between 50 and 95% water by weight relative to the total weight of the composition, very preferably between 65 and 80% water.
L'eau présente dans la composition selon l'invention peut être de toute origine. The water present in the composition according to the invention can be of any origin.
Préférentiellement au moins une partie de l'eau présente dans la composition selon l'invention est de l'eau source. De façon préférée au moins 3% de l'eau présente dans la composition selon l'invention est de l'eau de source, le pourcentage étant donné en poids par rapport au poids total d'eau présente dans la composition. Preferably at least part of the water present in the composition according to the invention is source water. Preferably at least 3% of the water present in the composition according to the invention is spring water, the percentage being given by weight relative to the total weight of water present in the composition.
Préférentiellement au moins une partie de l'eau présente dans la composition selon l'invention est de l'eau d'origine marine. Preferably at least part of the water present in the composition according to the invention is water of marine origin.
Selon un mode de réalisation, au moins une partie de l'eau présente dans la composition est de l'eau de source marine. De façon préférée au moins 3% de l'eau présente dans la composition selon l'invention est de l'eau de source marine, le pourcentage étant donné en poids par rapport au poids total d'eau présente dans la composition. According to one embodiment, at least part of the water present in the composition is water from a marine source. Preferably at least 3% of the water present in the composition according to the invention is marine spring water, the percentage being given by weight relative to the total weight of water present in the composition.
En plus de l'eau et du mélange de collagènes, la composition selon l'invention peut comprendre d'autres constituants, ceux-ci devant être dermatologiquement et/ou cosmétiquement acceptables. Il peut s'agir notamment d'excipients ou de principes actifs. Préférentiellement, la composition selon l'invention comprend : au moins une huile végétale, comme par exemple une huile de tournesol ou de grenade ou de pépin de raisin, et/ou au moins un principe actif cicatrisant et/ou hydratant et/ou antibactérien et/ou apaisant et/ou anti-irritant, comme par exemple squalane ou gel d'aloé vera, et/ou au moins un extrait végétal, comme par exemple extrait de punica granatum, ou extrait de fleur de sophora japonica, ou extrait de feuille de romarin, et/ou au moins un émulsionnant, comme par exemple Sorbitan isostearate ou polyacrylamide ou polysorbate 20, et/ou au moins un émollient, comme par exemple octyldodecanol ou propanediol ou caprylic, et/ou au moins un conservateur, comme par exemple sorbate de potassium, benzoate de sodium, alcool benzylique, acide dehydroacétique, et/ou au moins un stabilisateur, comme par exemple tocophérol, et/ou de la glycérine. In addition to the water and the mixture of collagens, the composition according to the invention can comprise other constituents, these having to be dermatologically and / or cosmetically acceptable. They may in particular be excipients or active ingredients. Preferably, the composition according to the invention comprises: at least one vegetable oil, such as for example a sunflower or pomegranate or grape seed oil, and / or at least one active principle which heals and / or moisturizes and / or antibacterial and / or soothing and / or anti-irritant, such as for example squalane or aloe vera gel, and / or at least one plant extract, such as for example extract of punica granatum, or extract of flower of sophora japonica, or leaf extract rosemary, and / or at least one emulsifier, such as for example Sorbitan isostearate or polyacrylamide or polysorbate 20, and / or at least one emollient, such as for example octyldodecanol or propanediol or caprylic, and / or at least one preservative, such as for example potassium sorbate, sodium benzoate, benzyl alcohol, dehydroacetic acid, and / or at least one stabilizer, such as for example tocopherol, and / or glycerin.
La composition, selon l'invention peut se présenter sous différentes formes adaptées à une application topique sur la peau et/ou les muqueuses. Il peut s'agir en particulier d'une crème, d'un sérum ou d'un gel ou d'une solution. The composition according to the invention can be provided in various forms suitable for topical application to the skin and / or the mucous membranes. It may in particular be a cream, a serum or a gel or a solution.
Procédé de fabrication de la composition selon l'invention Process for manufacturing the composition according to the invention
La composition selon l'invention peut être obtenue par tout procédé de fabrication adapté. The composition according to the invention can be obtained by any suitable manufacturing process.
En particulier la composition selon l'invention peut être obtenue par un procédé de fabrication comprenant au moins la mise en oeuvre des étapes suivantes : obtention d'au moins une solution de collagène(s) à partir de peaux d'esturgeon, dans le cas où il y a plusieurs solutions de collagène(s), mélange des solutions de collagène(s), mélange de solution obtenue avec les éventuels autres constituants de la composition. La composition selon l'invention peut également être obtenue par un procédé de fabrication comprenant au moins la mise en oeuvre des étapes suivantes : a. obtention d'une solution de collagène natif, préférentiellement à partir de peaux d'esturgeons, b. obtention d'une solution de collagène en gel, préférentiellement à partir de peaux d'esturgeons c. mélange des deux solutions pour obtenir une solution de collagène natif et de collagène en gel, d. mélange des constituants de la composition à température ambiante. In particular, the composition according to the invention can be obtained by a manufacturing process comprising at least the implementation of the following steps: obtaining at least one solution of collagen (s) from sturgeon skins, in the case of where there are several solutions of collagen (s), mixture of solutions of collagen (s), mixture of solution obtained with the possible other constituents of the composition. The composition according to the invention can also be obtained by a manufacturing process comprising at least the implementation of the following steps: a. obtaining a native collagen solution, preferably from sturgeon skins, b. obtaining a gel collagen solution, preferably from sturgeon skins c. mixing the two solutions to obtain a solution of native collagen and gel collagen, d. mixing of the constituents of the composition at room temperature.
La solution de collagène natif peut être obtenue partout moyen adapté. The native collagen solution can be obtained anywhere suitable medium.
Selon un mode de réalisation, l'étape a. comprend la mise en oeuvre des étapes suivantes : According to one embodiment, step a. includes the implementation of the following steps:
Lavage de la matière première contenant du collagène, préférentiellement de peaux de poisson, encore plus préférentiellement de peaux d'esturgeon et en particulier de peaux ventrales d'esturgeon ; le lavage est préférentiellement réalisé en deux sous-étapes : o un lavage basique à la soude NaOH, pour nettoyer les peaux o puis à l'eau pour neutraliser extraction à l'acide, filtration et centrifugation, précipitation du collagène par NaCI et centrifugation, solubilisation par ajout d'acide, dialyse pour éliminer le sel (NaCI), concentration tangentielle. Washing of the raw material containing collagen, preferably fish skins, even more preferably sturgeon skins and in particular sturgeon ventral skins; the washing is preferably carried out in two sub-steps: o a basic washing with sodium hydroxide NaOH, to clean the skins o then with water to neutralize extraction with acid, filtration and centrifugation, precipitation of the collagen by NaCl and centrifugation, solubilization by addition of acid, dialysis to remove the salt (NaCl), tangential concentration.
Le procédé d'obtention du collagène natif est préférentiellement réalisé à une température inférieure à 35°C. Il garde ainsi sa triple hélice et ses propriétés de collagène natif. The process for obtaining native collagen is preferably carried out at a temperature below 35 ° C. It thus keeps its triple helix and its native collagen properties.
La solution de collagène en gel peut être obtenue par tout moyen adapté. Selon un mode de réalisation, l'étape b. comprend la mise en oeuvre des étapes suivantes : The gel collagen solution can be obtained by any suitable means. According to one embodiment, step b. includes the implementation of the following steps:
Lavage de la matière première contenant du collagène, préférentiellement de peaux de poisson, encore plus préférentiellement de peaux d'esturgeon et en particulier de peaux ventrales d'esturgeon ; le lavage est préférentiellement réalisé en deux sous-étapes : o un lavage basique à la soude NaOH, pour nettoyer les peaux o puis à l'eau pour neutraliser extraction à l'acide filtration et centrifugation précipitation du collagène par NaCI et centrifugation solubilisation par ajout d'acide dialyse pour éliminer le sel (NaCI) concentration tangentielle cuisson à 60°C, préférentiellement sous agitation tamisage, filtration sur charbon actif. Washing of the raw material containing collagen, preferably fish skins, even more preferably sturgeon skins and in particular sturgeon ventral skins; the washing is preferably carried out in two sub-steps: o a basic washing with sodium hydroxide NaOH, to clean the skins o then with water to neutralize extraction with acid filtration and centrifugation precipitation of collagen by NaCl and centrifugation, solubilization by addition of dialysis acid to remove the salt (NaCl) tangential concentration, cooking at 60 ° C., preferably with stirring, sieving, filtration through activated carbon.
Les deux solutions (collagène natif et collagène en gel) sont ensuite mélangées pour former une solution de collagènes. The two solutions (native collagen and gel collagen) are then mixed to form a collagen solution.
La solution de collagènes est ensuite mélangée à l'eau et aux autres constituants éventuels de la composition, préférentiellement à température ambiante pour préserver les qualités originelles des actifs et notamment des ingrédients d'origine naturelle constituant la composition selon l'invention. Avantageusement, la mise en oeuvre du procédé à température ambiante présente un intérêt économique et environnemental. The collagen solution is then mixed with water and with the other optional constituents of the composition, preferably at room temperature in order to preserve the original qualities of the active agents and in particular of the ingredients of natural origin constituting the composition according to the invention. Advantageously, the implementation of the process at ambient temperature is of economic and environmental interest.
Utilisations de la composition Uses of the composition
La composition selon l'invention présente une efficacité sur la peau et/ou les muqueuses, en particulier une efficacité cicatrisante. The composition according to the invention has an effectiveness on the skin and / or the mucous membranes, in particular a healing effectiveness.
L'invention a donc également pour objet la composition pour son utilisation dans le traitement de la peau et/ou des muqueuses. La composition peut être utilisée comme médicament, essentiellement comme médicament dermatologique, ou comme dispositif médical ou encore comme composition cosmétique ou dermocosmétique. A subject of the invention is therefore also the composition for its use in the treatment of the skin and / or the mucous membranes. The composition can be used as a medicament, essentially as a dermatological medicament, or as a medical device or else as a cosmetic or dermocosmetic composition.
Notamment l'invention a pour objet la composition pour son utilisation en application topique sur la peau et/ou les muqueuses pour un effet cicatrisant. In particular, a subject of the invention is the composition for its use in topical application to the skin and / or the mucous membranes for a healing effect.
L'invention vise aussi l'utilisation de la composition sur une peau ou des muqueuses saine(s) en application topique pour un effet cosmétique, notamment pour un effet cosmétique anti-âge, pour prévenir et/ou lutter contre le vieillissement cutané. The invention also relates to the use of the composition on healthy skin or mucous membranes in topical application for a cosmetic effect, in particular for an anti-aging cosmetic effect, for preventing and / or combating skin aging.
Ainsi, l'invention vise aussi une utilisation cosmétique sur une peau ou des muqueuses saine(s) en application topique pour un effet cosmétique anti-âge, pour prévenir et/ou lutter contre le vieillissement cutané normal lié à l'âge. Thus, the invention is also aimed at cosmetic use on healthy skin or mucous membranes in topical application for an anti-aging cosmetic effect, to prevent and / or fight against normal aging of the skin.
Avantageusement, la composition selon l'invention peut également être utilisée comme crème conductrice pour le traitement de la peau et/ou des muqueuses par diathermie et/ou radiofréquence. L'utilisation thérapeutique ou cosmétique de la composition selon l'invention peut donc consister en cela. Aussi l'invention a également pour objet la composition pour son utilisation en application topique sur la peau et/ou les muqueuses comme composition conductrice pour le traitement de la peau et/ou des muqueuses par diathermie et/ou radiofréquence. Advantageously, the composition according to the invention can also be used as a conductive cream for the treatment of the skin and / or the mucous membranes by diathermy and / or radiofrequency. The therapeutic or cosmetic use of the composition according to the invention can therefore consist of this. A subject of the invention is also the composition for its use. in topical application to the skin and / or the mucous membranes as a conductive composition for the treatment of the skin and / or the mucous membranes by diathermy and / or radiofrequency.
Aussi la composition selon l'invention peut être utilisée avec ou sans application de radiofréquences. En application avec des radiofréquences, préférentiellement la composition est appliquée de façon circulaire sur la zone à traiter avec l'appareil de radiofréquences de manière à recouvrir toute la surface et 2mm d'épaisseur environ. Le praticien passe alors le manipule sur la zone à traiter en suivant un protocole adapté à chaque problème pathologique ou cosmétique à traiter. Si besoin, il est possible de remettre de la crème en cours de réalisation du protocole. La conductivité de la composition selon l'invention est importante. Also the composition according to the invention can be used with or without application of radiofrequencies. In application with radiofrequencies, the composition is preferably applied in a circular manner to the area to be treated with the radiofrequency device so as to cover the entire surface and approximately 2 mm in thickness. The practitioner then passes the manipulation over the area to be treated by following a protocol adapted to each pathological or cosmetic problem to be treated. If necessary, it is possible to add more cream while the protocol is being carried out. The conductivity of the composition according to the invention is high.
Avantageusement, à la fin de la séance il n'est pas nécessaire d'essuyer la composition comme c'est le cas avec les crèmes conductrices ou gels conducteurs actuels. En effet, grâce à son double usage, la composition selon l'invention est absorbée par la peau et agit en tant que telle par ses propriétés intrinsèques, soutenant ainsi les propriétés régénérantes cosmétiques ou thérapeutiques reconnues de la radiofréquence. Advantageously, at the end of the session, it is not necessary to wipe off the composition as is the case with current conductive creams or conductive gels. Indeed, thanks to its dual use, the composition according to the invention is absorbed by the skin and acts as such through its intrinsic properties, thus supporting the recognized cosmetic or therapeutic regenerating properties of radiofrequency.
La radiofréquence provoque la vasodilatation dans la zone d'application, augmentant le flux sanguin et élevant la température localement provoquant un meilleur apport de nutriment et d'oxygène, et l'élimination des catabolites. Les effets de la température de la radiofréquence provoquent la dénaturation du collagène du derme favorisant la contraction immédiate et efficace de ses fibres, activant les fibroblastes et entraînant la néo-collagénisation conduisant à la réorganisation des fibres de collagène et au remodelage du tissu. Pendant le traitement, la température à la surface de la peau atteint 40 à 42°C, et 50 à 60°C en profondeur. Le collagène natif présent dans la composition selon l'invention est dénaturé lors de l'utilisation de la radiofréquence. La chaîne en triple hélice est défaite sous l'effet de la chaleur (dès 35°C) ; elle vient pénétrer plus facilement le derme car son poids moléculaire sera plus faible et la vasodilatation des pores favorise sa pénétration dans le derme. Cela vient renforcer l'effet du collagène gel. La radiofréquence peut amener plus loin en profondeur les molécules de collagène dans les couches du derme. The radio frequency causes vasodilation in the area of application, increasing blood flow and raising the temperature locally causing better supply of nutrients and oxygen, and the elimination of catabolites. The effects of radiofrequency temperature cause the denaturation of collagen in the dermis, promoting immediate and effective contraction of its fibers, activating fibroblasts and leading to neo-collagenization leading to the reorganization of collagen fibers and tissue remodeling. During the treatment, the temperature on the surface of the skin reaches 40 to 42 ° C, and 50 to 60 ° C in depth. The native collagen present in the composition according to the invention is denatured during the use of radiofrequency. The triple helix chain is undone under the effect of heat (from 35 ° C); it penetrates the dermis more easily because its molecular weight will be lower and the vasodilation of the pores promotes its penetration into the dermis. This reinforces the effect of the collagen gel. Radio frequency can take collagen molecules deeper into the layers of the dermis.
L'invention est à présent illustrée par des exemples et des résultats d'essais. The invention is now illustrated by examples and test results.
EXEMPLES EXAMPLES
Exemple de composition selon l'invention Example of composition according to the invention
Un exemple de composition selon l'invention, se présentant sous forme de crème est obtenu par le mélange à température ambiante de constituants, qui dans la composition finie est constituée par (les teneurs étant données en pourcentage en poids par rapport au poids de la composition) : collagène natif de peaux d'esturgeon : 0,01 à 1 collagène gel de peaux d'esturgeon : 0,01 à 1 glycérine : 0,2 à B squalane : 3 à 6 huile de grenade : 1 à 2 extrait de fleur de sophora japonica : 0,001 à 0,05 extrait de grenade : 0,001 à 0,05 huile essentielle de niaouli : 0,01 à 0,1 huile de tournesol : 0,1 à 1 eau de source marine : 2 à 5 - Eau : 75 à 88 caprylic/capric triglycéride : 5 à 8 émulsionnant : 1 à 3 conservateurs : QS An example of a composition according to the invention, which is in the form of a cream, is obtained by mixing constituents at room temperature, which in the finished composition consists of (the contents being given in percentage by weight relative to the weight of the composition ): native collagen of sturgeon skins: 0.01 to 1 collagen gel of sturgeon skins: 0.01 to 1 glycerin: 0.2 to B squalane: 3 to 6 pomegranate oil: 1 to 2 flower extract of sophora japonica: 0.001 to 0.05 pomegranate extract: 0.001 to 0.05 essential oil of niaouli: 0.01 to 0.1 sunflower oil: 0.1 to 1 marine spring water: 2 to 5 - Water: 75 to 88 caprylic / capric triglyceride: 5 to 8 emulsifier: 1 to 3 preservatives: QS
Démonstration de l'efficacité de la composition selon l'invention Demonstration of the effectiveness of the composition according to the invention
I. Etude sur expiants de peau de l'effet cicatrisant et anti-âge de la composition selon l'invention Différents produits ont été testés contenant des concentrations différentes de collagène et des formes différentes de collagène. I. Study on skin explants of the healing and anti-aging effect of the composition according to the invention Various products were tested containing different concentrations of collagen and different forms of collagen.
Les différentes compositions testées sont décrites dans le tableau 1 (valeurs de teneur en collagène, pourcentage en poids par rapport au poids total de la composition ; le reste de la composition est celle de l'exemple de composition selon l'invention). The different compositions tested are described in Table 1 (collagen content values, percentage by weight relative to the total weight of the composition; the remainder of the composition is that of the example of composition according to the invention).
[Tableau 1]
Figure imgf000014_0001
[Table 1]
Figure imgf000014_0001
Les tests d'effet cicatrisant et anti-âges de ces compositions ont été réalisés sur des expiants de peau. Pour les deux tests, les résultats ont été obtenus après traitement histologique et étude de la morphologie générale : The healing and anti-aging effect tests of these compositions were carried out on skin explants. For the two tests, the results were obtained after histological treatment and study of the general morphology:
Traitements histologiques : Après 24h dans le formol tamponné, les prélèvements ont été déshydratés et imprégnés en paraffine à l'aide d'un automate de déshydratation Leica PEARL. Ils ont été mis en bloc à l'aide d'une station d'enrobage Leica EG 1160. Des coupes de 5 pm ont été réalisées à l'aide d'un microtome type Minot, Leica RM 2125 et montées sur des lames de verre histologiques Superfrost®. Les échantillons congelés ont été coupés en sections de 7pm d'épaisseur à l'aide d'un cryostat Leica CM 3050. Les sections ont ensuite été montées sur lames de verre Superfrost® Plus. Les observations microscopiques ont été réalisées en microscopie optique, à l'aide d'un microscope Leica type DMLB ou Olympus BX43. Les prises de vue ont été réalisées avec une caméra Olympus DP72 et le logiciel CellAD. Histological treatments: After 24 hours in buffered formalin, the samples were dehydrated and impregnated with paraffin using a Leica PEARL automatic dehydration machine. they have was en bloc using a Leica EG 1160 embedding station. 5 µm sections were made using a Minot type microtome, Leica RM 2125 and mounted on Superfrost histological glass slides. ® . The frozen samples were cut into sections 7 μm thick using a Leica CM 3050 cryostat. The sections were then mounted on Superfrost ® Plus glass slides. The microscopic observations were carried out by optical microscopy, using a Leica DMLB or Olympus BX43 type microscope. The shots were taken with an Olympus DP72 camera and Cell A D software.
Morphologie générale : La morphologie générale a été observée sur coupes en paraffine après coloration au trichrome de Masson variante de Goldner. Elle a été évaluée par un examen microscopique. General morphology: The general morphology was observed on paraffin sections after staining with Masson's trichrome variant of Goldner. It was assessed by microscopic examination.
1.1. Effet cicatrisant de la composition selon l'invention 1.1. Healing effect of the composition according to the invention
Afin de tester les propriétés cicatrisantes de la composition selon l'invention (P3) et des autres produits PI à P5, une étude a été menée sur des expiants de peaux. In order to test the healing properties of the composition according to the invention (P3) and of the other products P1 to P5, a study was carried out on explants of skin.
Le protocole opératoire de l'essai est le suivant : The operating protocol for the test is as follows:
Préparation des expiants: 6 expiants rectangulaires de 10x15 mm, avec blessure par lot, ont été préparés à partir d'une plastie abdominale d'une femme caucasienne de 60 ans. Les expiants ont été mis en survie en milieu de culture à 37°C en atmosphère humide, enrichie de 5 % de C02. Preparation of explants: 6 rectangular explants of 10x15 mm, with wound per batch, were prepared from an abdominoplasty of a 60-year-old Caucasian woman. The explants were left to survive in a culture medium at 37 ° C. in a humid atmosphere, enriched with 5% CO 2.
Réalisation des lésions par Blessure mécanique : A J0 sur les expiants, deux blessures par expiant ont été réalisées à l'aide d'un punch à biopsies de 3.5 mm de diamètre. Les lésions ont été réalisées juste avant l'application des produits testés. Creation of lesions by mechanical injury: On D0 on the explants, two wounds by explant were performed using a 3.5 mm diameter biopsy punch. The lesions were produced just before the application of the tested products.
Application des produits : A J0 (après blessures) et J3, J5 et J7, les produits testés ont été appliqués en topique, à raison de 3 pl pour les expiants rectangulaires afin d'obtenir une concentration de 2mg par cm2. Successivement les produits ont été étalés à l'aide d'une spatule.Application of the products: On D0 (after injuries) and D3, D5 and D7, the tested products were applied topically, at a rate of 3 μl for the rectangular explants in order to obtain a concentration of 2 mg per cm 2 . The products were successively spread using a spatula.
Les expiants des lots témoin n'ont reçu aucun traitement à l'exception du renouvellement du milieu de culture, pour moitié (lmL/puits) à J3. The explants of the control batches received no treatment except for the renewal of the culture medium, half (1mL / well) on D3.
Prélèvements : A J0, les 3 expiants des lots T0 et Bo ont été prélevés et coupés en deux. Une partie a été fixée dans une solution de formol tamponnée, et l'autre a été congelée à -80°C. A J4 et J10, 3 expiants de chaque lot ont été prélevés et traités de la même façon qu'à J10. Samples: On D0, the 3 explants of batches T0 and Bo were taken and cut in half. One part was fixed in buffered formalin solution, and the other was frozen at -80 ° C. On D4 and D10, 3 explants from each batch were taken and treated in the same way as on D10.
Les résultats obtenus avec la composition P3 sont présentés sur les figures la (morphologie générale), lb (témoin à J4) et le (invention à J4). The results obtained with composition P3 are shown in Figures la (general morphology), lb (control at D4) and (invention at D4).
La figure la représente la morphologie générale de la zone lésée. Il n'y a pas de bourgeon de croissance. Figure la shows the general morphology of the injured area. There is no growth bud.
La figure lb représente la morphologie générale de la zone lésée du témoin non traité à J4. Le bourgeon de croissance présente une longueur de 150pm. FIG. 1b represents the general morphology of the injured area of the untreated control on D4. The growth bud has a length of 150 µm.
La figure le représente la morphologie générale de la zone lésée après 4 jours de traitement avec la composition selon l'invention (PB). La morphologie générale est bonne dans l'épiderme et dans le derme. Le stratum corneum présente un aspect peu épais et peu feuilleté, le relief de la jonction dermo-épidermique (JDE) est faible et la densité du derme papillaire est nette. Figure 1c shows the general morphology of the injured area after 4 days of treatment with the composition according to the invention (PB). The general morphology is good in the epidermis and in the dermis. The stratum corneum has a thin and slightly laminated appearance, the relief of the dermo-epidermal junction (DEJ) is low and the density of the papillary dermis is clear.
On constate que la composition selon l'invention, après 4 jours de traitement présente une activité cicatrisante plus importante que le témoin, principalement en favorisant à la fois la prolifération et la migration des kératinocytes du bourgeon de croissance. It is observed that the composition according to the invention, after 4 days of treatment, exhibits greater healing activity than the control, mainly by promoting both the proliferation and the migration of the keratinocytes of the growth bud.
De plus, les résultats obtenus pour les produits PI à P5 sont présentés ci-après : In addition, the results obtained for the products PI to P5 are presented below:
Le produit PI, après 4 jours de traitement, présente une activité cicatrisante principalement en favorisant la migration des kératinocytes et donc l'avancé du bourgeon de croissance. Cette activité n'est plus observée après 10 jours. The PI product, after 4 days of treatment, exhibits healing activity mainly by promoting the migration of keratinocytes and therefore the advancement of the growth bud. This activity is no longer observed after 10 days.
Le produit P2 après 4 jours de traitement, présente une activité cicatrisante, principalement en favorisant la prolifération des kératinocytes au niveau du bourgeon de croissance. The product P2 after 4 days of treatment exhibits healing activity, mainly by promoting the proliferation of keratinocytes in the growth bud.
Le produit P3, après 4 jours de traitement, présente une activité cicatrisante, principalement en favorisant à la fois la prolifération et la migration des kératinocytes du bourgeon de croissance. Après 10 jours de traitement, il ne favorise que la prolifération des kératinocytes du bourgeon de croissance. The product P3, after 4 days of treatment, exhibits healing activity, mainly by promoting both the proliferation and the migration of keratinocytes from the growth bud. After 10 days of treatment, it only promotes the proliferation of keratinocytes in the growth bud.
Le produit P4, après 4 jours de traitement, ne présente pas d'activité cicatrisante. Mais après 10 jours de traitement, il favorise la prolifération des kératinocytes du bourgeon de croissance. The product P4, after 4 days of treatment, does not exhibit any healing activity. But after 10 days of treatment, it promotes the proliferation of keratinocytes in the growth bud.
Le produit P5, après 4 ou 10 jours de traitement, ne présente pas d'activité cicatrisante. The product P5, after 4 or 10 days of treatment, does not exhibit any healing activity.
Ainsi l'association de collagène natif et de collagène en gel est importante pour obtenir l'effet cicatrisant. Thus the association of native collagen and gel collagen is important to obtain the healing effect.
1.2. Effet anti-âge de la composition selon l'invention 1.2. Anti-aging effect of the composition according to the invention
Afin de tester les propriétés anti-âges de la composition selon l'invention (P3) et des autres produits PI à P5, une étude a été menée sur des expiants de peaux. In order to test the anti-aging properties of the composition according to the invention (P3) and of the other products P1 to P5, a study was carried out on skin explants.
Le protocole opératoire de l'essai est le suivant : The operating protocol for the test is as follows:
- Préparation des expiants : 45 circulaires avec un diamètre de 12±1 mm, ont été préparés à partir d'une plastie abdominale d'une femme caucasienne de 60 ans (référence: P2124-AB60). Les expiants ont été mis en survie en milieu de culture à 37°C en atmosphère humide, enrichie de 5 % de C02- Preparation of explants: 45 circulars with a diameter of 12 ± 1 mm, were prepared from an abdominoplasty of a 60-year-old Caucasian woman (reference: P2124-AB60). The explants were left to survive in culture medium at 37 ° C in a humid atmosphere, enriched with 5% C02.
- Application des produits : A J0, J3, J5 et J7, les produits testés ont été appliqués en topique, à raison de 2mg par cm2. Successivement les produits ont été étalés à l'aide d'une spatule. - Application of the products: On D0, D3, D5 and D7, the products tested were applied topically, at a rate of 2 mg per cm 2 . The products were successively spread using a spatula.
Les expiants des lots témoin n'ont reçu aucun traitement à l'exception du renouvellement du milieu de culture, pour moitié (lmL/puits) à JB, J5 et J7. The explants of the control batches received no treatment except for the renewal of the medium. of culture, for half (lmL / well) on JB, D5 and D7.
Prélèvements : A JO, les 3 expiants des lots T0 ont été prélevés et coupés en deux. Une partie a été fixée dans une solution de formol tamponnée, et l'autre a été congelée à -80°C. A J4 et J10, 3 expiants de chaque lot ont été prélevés et traités de la même façon qu'à JO. Selon les dispositions prévues dans le plan d'étude, les jours de traitements et de prélèvements ont été modifiés pour adapter le planning de l'étude en fonction des jours ouvrés. Samples: At OJ, the 3 explants of the T0 batches were taken and cut in two. One part was fixed in buffered formalin solution, and the other was frozen at -80 ° C. On D4 and D10, 3 explants from each batch were taken and treated in the same way as in OJ. According to the provisions provided for in the study plan, the days of treatments and samples were modified to adapt the planning of the study according to the working days.
Les résultats sont présentés sur les figures 2a (morphologie générale), 2b (témoin à J4), 2c (invention à J4), 2d (témoin à J10) et 2e (invention à J10). The results are presented in FIGS. 2a (general morphology), 2b (control on D4), 2c (invention on D4), 2d (control on D10) and 2e (invention on D10).
La figure 2a représente la morphologie de l'expiant sur peau normale. La morphologie générale est bonne dans l'épiderme et dans le derme. Le stratum corneum présente un aspect peu épais et peu feuilleté, le relief de la jonction dermo-épidermique (JDE) est faible et la densité du derme papillaire est nette. FIG. 2a represents the morphology of the explant on normal skin. The general morphology is good in the epidermis and in the dermis. The stratum corneum has a thin and slightly laminated appearance, the relief of the dermo-epidermal junction (DEJ) is low and the density of the papillary dermis is clear.
La figure 2b représente la morphologie de l'expiant sans traitement à J4 : La morphologie générale est assez bonne dans l'épiderme et bonne dans le derme. Le stratum corneum présente un aspect modérément épais et feuilleté, le relief de la jonction dermo-épidermique (JDE) est modéré et la densité du derme papillaire est modérée. FIG. 2b represents the morphology of the explant without treatment on D4: The general morphology is quite good in the epidermis and good in the dermis. The stratum corneum presents a moderately thick and laminated appearance, the relief of the dermo-epidermal junction (DEJ) is moderate and the density of the papillary dermis is moderate.
La figure 2c représente la morphologie de l'expiant après 4 jours d'application de la composition P3 : l'invention induit une augmentation de la densité du derme papillaire. FIG. 2c represents the morphology of the explant after 4 days of application of the composition P3: the invention induces an increase in the density of the papillary dermis.
La figure 2d représente la morphologie de l'explant sans traitement après 10 jours : la morphologie générale est très légèrement altérée dans l'épiderme et bonne dans le derme. Le stratum corneum présente un aspect assez épais et modérément feuilleté, le relief de la jonction dermo-épidermique (JDE) est modéré et la densité du derme papillaire est faible. FIG. 2d represents the morphology of the explant without treatment after 10 days: the general morphology is very slightly altered in the epidermis and good in the dermis. The stratum corneum presents a rather thick and moderately laminated appearance, the relief of the dermo-epidermal junction (DEJ) is moderate and the density of the papillary dermis is low.
La figure 2e représente la morphologie de l'expiant après 10 jours d'application de la composition P3 : l'invention induit une augmentation de la densité du derme papillaire. FIG. 2e represents the morphology of the explant after 10 days of application of the composition P3: the invention induces an increase in the density of the papillary dermis.
On constate que la composition selon l'invention est bien tolérée par la peau et n'induit pas d'altération de la viabilité cellulaire dans l'épiderme ni le derme. A J4, la composition selon l'invention présente une activité anti-âge en améliorant la densité du derme nettement visible, et qui se poursuit à J10. It is observed that the composition according to the invention is well tolerated by the skin and does not induce any deterioration in cell viability in the epidermis or in the dermis. On D4, the composition according to the invention exhibits anti-aging activity by improving the density of the dermis which is clearly visible, and which continues on D10.
De plus, les résultats obtenus pour les produits PI à P5 sont présentés ci-après : In addition, the results obtained for the products PI to P5 are presented below:
- Le produit PI, après 4 jours de traitement, n'induit pas d'augmentation de la densité du derme papillaire. Une augmentation est constatée au bout de 10 jours. - The PI product, after 4 days of treatment, does not induce an increase in the density of the papillary dermis. An increase is seen after 10 days.
- Le produit P2, après 4 jours de traitement, n'induit pas une augmentation du derme papillaire. - Le produit PB, après 4 jours de traitement et après 10 jours de traitement, induit une augmentation de la densité du derme papillaire. - The product P2, after 4 days of treatment, does not induce an increase in the papillary dermis. - The PB product, after 4 days of treatment and after 10 days of treatment, induces an increase in the density of the papillary dermis.
- Le produit P4, après 4 jours de traitement, n'induit pas d'augmentation de la densité du derme papillaire. Une augmentation est constatée au bout de 10 jours. - The product P4, after 4 days of treatment, does not induce an increase in the density of the papillary dermis. An increase is seen after 10 days.
- Le produit P5, après 4 jours de traitement n'induit pas d'augmentation de la densité du derme papillaire. - The product P5, after 4 days of treatment does not induce an increase in the density of the papillary dermis.
II. Effet de la composition selon l'invention avec l'application de radiofréquences II. Effect of the composition according to the invention with the application of radiofrequencies
Les tests effectués avec application de radiofréquences montrent une conductivité importante.Tests carried out with the application of radiofrequencies show significant conductivity.
De plus, un exemple d'efficacité est présenté ci-après. In addition, an example of efficiency is shown below.
- Sujet : Femme de 46 ans présentant des vergetures post-partum de 15 ans et la cicatrice d'une abdominoplastie de 2,5 ans. - Subject: 46-year-old woman with 15-year-old postpartum stretch marks and the scar from a 2.5-year-old tummy tuck.
- Matériel utilisé : Appareil de radiofréquence de la marque Fisioline, modèle Radiant - Equipment used: Fisioline brand radiofrequency device, Radiant model
- Protocole utilisé : Préparation de la patiente (installation de la plaque de retour). Application de la composition de l'exemple sur la zone traitée puis passage du manipule en mouvement circulaire pendant 7 à 15 min selon un programme spécifique : - Protocol used: Preparation of the patient (installation of the return plate). Application of the composition of the example to the treated area then passage of the manipulator in circular motion for 7 to 15 min according to a specific program:
- 1er passage en multifréquence en mode capacitif - 1st switch to multifrequency in capacitive mode
- 2ème passage en mode résistif - 2nd passage in resistive mode
- dernier passage en mode bipolaire. - last switch to bipolar mode.
Deux autres séances ont lieu suivant le même procédé à 15 jours (2 semaines) d'intervalle soit 3 séances sur une durée de traitement effectué dans un délai de 45 jours. Two other sessions take place following the same process at 15 day (2 week) intervals, ie 3 sessions over a period of treatment carried out within 45 days.
Les résultats sont présentés sur les figures 3a et 3b. The results are shown in Figures 3a and 3b.
La figure 3a est une photographie de l'abdomen d'une femme de 46 ans présentant des vergetures post-partum et des cicatrices suite à une abdominoplastie. On y voit des vergetures marquées d'apparence « peau d'écaille », et des cicatrices verticale et horizontale adhérentes. Figure 3a is a photograph of the abdomen of a 46 year old woman with postpartum stretch marks and scarring following a tummy tuck. We see marked stretch marks with a "scale skin" appearance, and adherent vertical and horizontal scars.
La figure 3b est une photographie de contrôle de l'abdomen un mois après la fin du traitement (3 séances de radiofréquence avec application de composition selon l'invention réparties sur 45 jours). La peau est plus lisse, tonique et élastique. La cicatrice horizontale et verticale est atténuée. Les vergetures sont extrêmement réduites. L'adhérence de la cicatrice verticale a disparu. FIG. 3b is a control photograph of the abdomen one month after the end of the treatment (3 radiofrequency sessions with application of the composition according to the invention spread over 45 days). The skin is smoother, toned and elastic. The horizontal and vertical scar is reduced. Stretch marks are extremely reduced. The adhesion of the vertical scar has disappeared.

Claims

Revendications Claims
[Revendication 1] Composition adaptée à une application topique sur la peau ou les muqueuses, caractérisée en ce qu'elle comprend au moins de l'eau et au moins un mélange de collagènes, ledit mélange de collagènes comprenant au moins : [Claim 1] Composition suitable for topical application to the skin or the mucous membranes, characterized in that it comprises at least water and at least one mixture of collagens, said mixture of collagens comprising at least:
- du collagène natif, les molécules de collagène natif présentant des poids moléculaires compris entre 150 et 300000 Daltons, et - native collagen, native collagen molecules having molecular weights between 150 and 300,000 Daltons, and
- du collagène en gel, les molécules de collagène en gel présentant des poids moléculaires compris entre 100 et 150000 Daltons. - gel collagen, the gel collagen molecules having molecular weights between 100 and 150,000 Daltons.
[Revendication 2] Composition selon la revendication précédente, caractérisée en ce que le collagène est obtenu à partir de peau d'esturgeon. [Claim 2] Composition according to the preceding claim, characterized in that the collagen is obtained from sturgeon skin.
[Revendication 3] Composition selon l'une des revendications précédentes, caractérisée en ce que le ou les collagènes comprend (comprennent) : [Claim 3] Composition according to one of the preceding claims, characterized in that the collagen (s) comprises (comprise):
- une teneur en Glycine comprise entre 21 et 26%, - a Glycine content of between 21 and 26%,
- une teneur en hydroxyproline comprise entre 8 et 18%, - a hydroxyproline content of between 8 and 18%,
- une teneur en proline comprise entre 9 et 14%. - a proline content of between 9 and 14%.
[Revendication 4] Composition selon l'une des revendications précédentes, caractérisée en ce qu'elle comprend au moins 0,1% de collagènes en poids par rapport au poids total de la composition. [Claim 4] Composition according to one of the preceding claims, characterized in that it comprises at least 0.1% of collagens by weight relative to the total weight of the composition.
[Revendication 5] Composition selon l'une des précédentes revendications, caractérisée en ce qu'elle comprend entre 0,1 et 10% de collagènes en poids par rapport au poids total de la composition. [Claim 5] Composition according to one of the preceding claims, characterized in that it comprises between 0.1 and 10% of collagens by weight relative to the total weight of the composition.
[Revendication 6] Composition selon l'une des précédentes revendications, caractérisée en ce qu'elle comprend entre 50 et 95% d'eau en poids par rapport au poids total de la composition. [Claim 6] Composition according to one of the preceding claims, characterized in that it comprises between 50 and 95% water by weight relative to the total weight of the composition.
[Revendication 7] Composition selon l'une des précédentes revendications, caractérisée en ce que le mélange de collagènes comprend entre 10 et 40% de collagène natif et entre 60 et 90% de collagène en gel, les pourcentages étant donnés en poids par rapport au poids total de matières sèches du mélange de collagènes. [Claim 7] Composition according to one of the preceding claims, characterized in that the mixture of collagens comprises between 10 and 40% of native collagen and between 60 and 90% of collagen in gel, the percentages being given by weight relative to the total weight of dry matter of the collagen mixture.
[Revendication 8] Composition selon l'une des précédentes revendications, caractérisée en ce que le collagène natif a été obtenu par un procédé mis en oeuvre à une température inférieure à 35°C. [Claim 8] Composition according to one of the preceding claims, characterized in that the native collagen has been obtained by a process carried out at a temperature below 35 ° C.
[Revendication 9] Composition selon l'une des précédentes revendications, caractérisée en ce qu'au moins une partie de l'eau est de l'eau de source. [Claim 9] Composition according to one of the preceding claims, characterized in that at least part of the water is spring water.
[Revendication 10] Composition selon l'une des précédentes revendications, caractérisée en ce qu'au moins une partie de l'eau est d'origine marine. [Claim 10] Composition according to one of the preceding claims, characterized in that at least part of the water is of marine origin.
[Revendication 11] Composition selon l'une des précédentes revendications, caractérisée en ce qu'elle comprend également : [Claim 11] Composition according to one of the preceding claims, characterized in that it also comprises:
- au moins une huile végétale, et/ou - at least one vegetable oil, and / or
- au moins un principe actif cicatrisant et/ou hydratant et/ou antibactérien et/ou apaisant et/ou anti-irritation, - at least one healing and / or moisturizing and / or antibacterial and / or soothing and / or anti-irritation active principle,
- au moins un extrait végétal, et/ou - at least one plant extract, and / or
- au moins un émulsionnant, et/ou - at least one emulsifier, and / or
- au moins un émollient, et/ou - at least one emollient, and / or
- au moins un conservateur, et/ou - at least one preservative, and / or
- au moins un stabilisateur, et/ou - at least one stabilizer, and / or
- de la glycérine. - glycerin.
[Revendication 12] Composition selon l'une des précédentes revendications, caractérisée en ce qu'elle se présente sous forme de crème, de sérum, d'une solution ou de gel. [Claim 12] Composition according to one of the preceding claims, characterized in that it is provided in the form of a cream, a serum, a solution or a gel.
[Revendication 13] Composition selon l'une des précédentes revendications, pour son utilisation dans le traitement de la peau et/ou des muqueuses. [Claim 13] Composition according to one of the preceding claims, for its use in the treatment of the skin and / or mucous membranes.
[Revendication 14] Composition selon l'une des revendications 1 à 12, pour son utilisation en application topique sur la peau et/ou les muqueuses pour un effet cicatrisant. [Claim 14] Composition according to one of claims 1 to 12, for its use in topical application to the skin and / or the mucous membranes for a healing effect.
[Revendication 15] Composition selon l'une des revendications 1 à 12, pour son utilisation en application topique sur la peau et/ou les muqueuses comme composition conductrice pour le traitement de la peau et/ou des muqueuses par diathermie et/ou radiofréquence. [Claim 15] Composition according to one of claims 1 to 12, for its use in topical application to the skin and / or the mucous membranes as a conductive composition for the treatment of the skin and / or the mucous membranes by diathermy and / or radiofrequency.
[Revendication 16] Composition selon l'une des revendications 1 à 12, pour son utilisation cosmétique en application topique sur une peau saine et/ou sur les muqueuses saines. [Claim 16] Composition according to one of Claims 1 to 12, for its cosmetic use in topical application to healthy skin and / or to healthy mucous membranes.
[Revendication 17] Composition pour son utilisation selon la précédente revendication, pour prévenir et/ou lutter contre le vieillissement cutané. [Claim 17] A composition for its use according to the preceding claim, for preventing and / or combating skin aging.
[Revendication 18] Procédé de fabrication d'une composition selon l'une des revendications 1 à 12, caractérisé en ce qu'il comprend au moins la mise en oeuvre des étapes suivantes : a. obtention d'une solution de collagène natif, b. obtention d'une solution de collagène en gel, c. mélange des deux solutions pour obtenir un mélange de collagène natif et de collagène gel, d. mélange des constituants de la composition à température ambiante. [Claim 18] A method of manufacturing a composition according to one of claims 1 to 12, characterized in that it comprises at least the implementation of the following steps: a. obtaining a solution of native collagen, b. obtaining a gel collagen solution, vs. mixing the two solutions to obtain a mixture of native collagen and gel collagen, d. mixing of the constituents of the composition at room temperature.
PCT/EP2020/078473 2019-10-09 2020-10-09 Healing and conductive composition comprising collagen WO2021069698A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR1911195A FR3101777B1 (en) 2019-10-09 2019-10-09 HEALING AND CONDUCTIVE COMPOSITION COMPRISING AT LEAST ONE COLLAGEN FROM STURGEON SKIN
FRFR1911195 2019-10-09
FRFR1911192 2019-10-09
FR1911192A FR3101774A1 (en) 2019-10-09 2019-10-09 HEALING AND CONDUCTIVE COMPOSITION INCLUDING AT LEAST TWO COLLAGENS

Publications (1)

Publication Number Publication Date
WO2021069698A1 true WO2021069698A1 (en) 2021-04-15

Family

ID=73014472

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2020/078473 WO2021069698A1 (en) 2019-10-09 2020-10-09 Healing and conductive composition comprising collagen

Country Status (1)

Country Link
WO (1) WO2021069698A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2657352A1 (en) * 1990-01-25 1991-07-26 France Etat Armement New biological product for replacement of connective tissue, with a composite structure based on collagen, and process for its preparation
FR2732972A1 (en) * 1995-04-14 1996-10-18 Mathe Lab Prodn. of soluble collagen gel compsns.
US20100303898A1 (en) * 2009-04-10 2010-12-02 Interhealth Nutraceuticals, Inc. Collagen dispersion and method of producing same
CN102558345A (en) * 2012-02-13 2012-07-11 江苏大学 Method for extracting collagen from sturgeon skin
CN108938448A (en) * 2018-08-27 2018-12-07 白晋 A kind of RF beauty autologous collagen protein liquid and its application method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2657352A1 (en) * 1990-01-25 1991-07-26 France Etat Armement New biological product for replacement of connective tissue, with a composite structure based on collagen, and process for its preparation
FR2732972A1 (en) * 1995-04-14 1996-10-18 Mathe Lab Prodn. of soluble collagen gel compsns.
US20100303898A1 (en) * 2009-04-10 2010-12-02 Interhealth Nutraceuticals, Inc. Collagen dispersion and method of producing same
CN102558345A (en) * 2012-02-13 2012-07-11 江苏大学 Method for extracting collagen from sturgeon skin
CN108938448A (en) * 2018-08-27 2018-12-07 白晋 A kind of RF beauty autologous collagen protein liquid and its application method

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE GNPD [online] MINTEL; 22 August 2018 (2018-08-22), ANONYMOUS: "Collagen Dietary Supplement", XP055697063, retrieved from www.gnpd.com Database accession no. 5922127 *
DATABASE WPI Week 201266, Derwent World Patents Index; AN 2012-M26310, XP002799082 *
HAO S ET AL: "The characteristics of gelatin extracted from sturgeon (Acipenser baeri) skin using various pretreatments", FOOD CHEMISTRY, ELSEVIER LTD, NL, vol. 115, no. 1, 1 July 2009 (2009-07-01), pages 124 - 128, XP025993127, ISSN: 0308-8146, [retrieved on 20081206], DOI: 10.1016/J.FOODCHEM.2008.11.080 *
LIN WANG ET AL: "Characterization of collagen from the skin of Amur sturgeon (Acipenser schrenckii)", FOOD HYDROCOLLOIDS, vol. 38, 1 July 2014 (2014-07-01), NL, pages 104 - 109, XP055697400, ISSN: 0268-005X, DOI: 10.1016/j.foodhyd.2013.12.002 *

Similar Documents

Publication Publication Date Title
EP0289366B1 (en) Product comprising an organic compound of silicium combined with a cosmetic active substance
CN103080204B (en) It is suitable for the externally applied transdermal glycosaminoglycan preparation of beauty and medicinal usage
KR102259407B1 (en) Method for Obtaining Collagen Peptide from Starfish, Elastic Liposome Comprising Collagen Peptide Derived from Starfish and Cosmetic Composition Comprising Same
EP2459162A2 (en) Injectable composition combining a filling agent and a fibroblast growth medium
FR2478468A1 (en) HYALURONATE COMPOSITIONS AND COSMETIC PREPARATIONS CONTAINING SAME
JP2001522877A (en) Prolamin-vegetable polar lipid composite, process for its production and use thereof
FR2900155A1 (en) Avian cartilage hydrolyzate, useful e.g. to treat/prevent joint pain, comprises hydrolyzed type II collagen, chondroitin sulfate, hyaluronic acid and amino acids e.g. phenylalanine, lysine, tryptophan, hydroxyproline and hydroxylysine
FR2896154A1 (en) Cosmetic/dermatological composition, useful for treatment of skin against external aggressions, comprises chestnut leaves extract, chestnut milk, chestnut sugar and an essential oil
CA2909792C (en) Method for producing a mixture of neutral oligosaccharides extracted from flaxseed
CN111888279A (en) Method for promoting collagen production and corresponding medicine or cosmetic
WO2014131974A1 (en) Topical antimicrobial dermatological composition
CN103479567A (en) Epidermal growth factor complex lipidosome, and preparation method and application of lipidosome
EP3442658A1 (en) Dermocosmetic composition, production process of the topical composition, method for strengthening fragile nails and use of the composition
WO2021069698A1 (en) Healing and conductive composition comprising collagen
EP1786386A1 (en) Cosmetic use of at least one type of natural ac-n-ser-asp-lys-pro tetrapeptide or one of the analogs thereof in the form of a skin antiaging and restructuring agent
WO2008013342A1 (en) Cosmetic composition for exfoliating skin keratin
WO2021234074A1 (en) Composition comprising different specific collagens and uses on the skin
FR2503561A1 (en) CONTINUOUS FLEXIBLE FILM FOR COSMETIC AND PHARMACEUTICAL USE CONTAINING POLYPEPTIDES
FR3101777A1 (en) HEALING AND CONDUCTIVE COMPOSITION INCLUDING AT LEAST ONE COLLAGEN OF STURGEON SKIN
FR3101774A1 (en) HEALING AND CONDUCTIVE COMPOSITION INCLUDING AT LEAST TWO COLLAGENS
EP2692332B1 (en) Composition for the treatment of callus, corns and psoriasis
KR101446706B1 (en) Composition for skin rejuvenation comprising FGF
FR2919999A1 (en) Cosmetic/pharmaceutical composition, useful to treat e.g. loss of dermal/epidermal volume, for filling depressions on skin surface and to treat wrinkles, and/or restore facial fullness, comprises hyaluronic acid and divalent cation
CN111961119B (en) Application of polypeptide in preparation of medicine or cosmetic for promoting collagen secretion
JP2021500393A (en) Cosmetic use of plant elephant extract (Phytelephas sp.)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20797043

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20797043

Country of ref document: EP

Kind code of ref document: A1